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INTRODUCTION 
                   The siddha medicine is the old ancient system of medicine. This system has 
many curative medicines such as Peru noigal, Mukkutra noigal, Auto immune disorders 
and Skin diseases.  It has a unique feature like destroy the root cause of the disease and 
remedy for body, mind and soul. Siddha system of medicines not only cure diseases it also 
have preventive and rejuvenation aspects than other system. 
                  Siddha system classified the diseases on the basis of three Humours, namely 
Vatham, Pitham, Kabham. As per the siddha system diseases are classified into 4448 
diseases. Among 4448 diseases the Vadha diseases are 80 types and Pitha diseases are 42 
and Kabha diseases are 21 types are described by yugi munivar in  YUGI VAITHIYA 
CHINTHAMANI. 
                   The three vital humours namely as Vatham, Pitham, Kabham are circulate in 
the body system in different proportions. Each of them has different functions. Healthy 
body consists of proper combination of three humours. Some changes in Pancha Pootham 
and Kalangal it can changes or modified the three humours. The disturbances of the vatham 
which may reduced or exaggerated this leads to vadha diseases. 
                The most of the siddha medicines were prepared from the purified metals and 
minerals and animal products also. This clinical trial is discussed about poly herbal 
formulations of  SAGALA VATHA CHOORANAM  
               
                         “Nth;ghU jioghU kp;Q;rpdf;fhy; nky;y nky;y   
            gw;g nre;J}uk; ghNu" 
                              - gjpnzd; rpj;jh; ghba rpy;yiwf; Nfhit 
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                         According to this statement herbals are used in first and second to use 
minerals and metallic preparations to cure the disease. This research work is dealing with 
lumbar spondylosis. According to siddha this disease is commonly correlate in 
THANDAGA VATHAM 
                      Lumbar spondylosis is a degenerative changes in disc and lumbar spine. Disc 
degenerate is age related and starts in the third decade. Disc prolapse and Osteophytosis 
can formed root compression and indirect ischemic neuronal damage. 
                      Degeneration of spine is mostly common in 60 years however degeneration 
can begin as early as age 30 and there are many cases of lumbar symptoms appearing by 
age 40. 
                    Approximately 84% of men and 74% of womens are affected in lumbar 
spondylosis.  Lumbar spondylosis was most frequently affected at T9 –T10 and L3 vertebral 
levels. Lumbar spondylosis is most commonly affected in L5 and S1 levels. 
                     In AATHMA RAKSHAMIRTHAM a drug SAGALA VATHA 
CHOORANAM has been indicated for all types of vatha diseases. The ingredients of 
this Chooranam suppress the vatham by these factors an attempt was made to evaluate the 
therapeutic efficacy of SAGALAVATHA CHOORANAM in the treatment of 
THANDAGA VATHAM. 
 
 
 
 
 
 
 
Aim & Objectives
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                                       AIM AND OBJECTIVES 
 
                    The siddha saint yugimunivar is classified vadha diseases about 80 types.   In 
siddha system vatham is considered as the most primitive and curative of disease. 
Thandagavatham is one among the 80 types of vatha diseases.The disease Thandaga 
vatham can be correlated in modern science is “lumbar spondylosis” 
 To collect the literary evidence about Thandaga vatham in  siddha and 
modern aspects 
 To study the disease Thandaga vatham with various aetiology, pathology, 
clinical features, diagnosis, treatment aspects. 
 To diagnosis the disease Thandagavatham by using modern parameters as 
well as siddha diagnostic stools like Envagai thervugal. 
 To evaluate the clinical efficacy of trial drug SAGALA VATHA 
CHOORANAM in the treatment of THANDAGA VATHAM  (Lumbar 
spondylosis) 
 To evaluate the biochemical and pharmacological studies of trial medicine 
SAGALA VATHA CHOORANAM. 
 To study the disease with age, sex, socio economic status ,habits, and family 
history  
 To analyse the Therapeutic value of the clinical trial drug.   
 This study included pharmacological and toxicological study to evaluate the 
potency of the clinical trial medicine SAGALA VATHA CHOORANAM.        
 
 
 
 
 
Abstract
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ABSTRACT 
THANDAGA VATHAM (LUMBAR SPONDYLOSIS) is one among the most 
common problem in people. It is a degenerative disease. Lumbar spondylosis can include 
herniated disc, buldging disc, bone spurs, and osteo arthritic changes all of which are spinal 
abnormalities that run the risk of protruding into spinal canal and exerting pressure on 
spinal nerves. 
             The disease THANDAGA VATHAM can be correlated in modern medicine is 
LUMBAR SPONDYLOSIS. 
 The trial medicine Sagala Vatha Chooranam described in Aathma Raksha 
mirtham which indicates all types of vadha diseases. So I selected this trial drug poly 
herbal formulation namely Sagala Vatha Chooranam. 
             Biochemical and pharmacological studies were carried out for the clinical trial 
medicine. For the clinical trial 20 Out patients and 20 In patients were selected according 
to the inclusion and exclusion criteria. 
                  The patients were administered clinical trial medicine is Sagalavatha 
chooranam 2gm with water twice a day during the study period. 
                   The biochemical analysis of Sagala vatha Chooranam showed the presence 
of Calcium, Starch, Ferrous iron, Tannic acid, Amino acids, Unsaturated compound. 
                    The pharmacological study of the drug SAGALA VATHA CHOORANAM 
showed a good NSAID activity. 
                     At the end of the study 70 % of patients have good results and 30 % of patients 
have moderate response due to change of paruvakallangal and thega illakkanam. 
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                                          REVIEW OF LITERATURE 
SIDDHA ASPECTS 
                    In siddha system the diseases are develops due to the vitiations of three 
Thodams namely Vatham, Pitham, Kabham. 
According to Thirukural, 
“kpfpDk; FiwapDk; Neha; nra;Ak; E}Nyhh; 
                  tsp Kjyh vz;zpa %d;W””” 
                                                    - jpUts;Sth; 
             Vatham, Pitham, Kabham is called as Uyirthathukal. These are regulates the 
bodyFunctions and activities of human beings. When they disturb these produce diseases. 
             Vatham represents vayu, mind, dryness, pain, flatulence, sensitiveness, lightness, 
and also air. 
             Pitham represents gastric juice, bile, energy, heat, inflammation, anger, and 
irritation etc… 
             Kabham represents feeling of cold, heaviness, running of the nose, passing of 
mucoid discharge and also saliva. 
RELATION BETWEEN SUVAIGAL AND MUKKUTRAM 
                    Tastes are divided into 6 types, these are as follows, 
 Sweet 
 Salt 
 Sour 
 Bitter 
 Pungent 
 Astringent 
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S.NO  Mukkutram            Panjapootham         Suvai  
1. Vatham             Ether + Air    Bitter  
2. Pitham               Fire     - 
3. Kabham              Earth  + water    Sweet  
   
   Some tastes will aggravate vatham and some tastes neutralize the vatham. If the vatham 
is increased thus produce alteration in taste in tongue, this is useful for diagnosis of the 
disease. 
LOCATION: 
        According to Siddha maruthuvanga churukkam the vatham lives in abanam to navel. 
“ehnkd;w thjj;Jf; fpUg;gplNk Nfsha; 
              ehgpf;Ff; fPnod;W etpy yhFk;” 
                          -rpj;j kUj;Jthq;fr; RUf;fk; gf;f vz; 140 
Vatham is lives in other places are  
          Abanan                                  Malam 
          Idakalai                                 Unthiyin keel moolam 
          Kaamakkodi                         Hip bone 
          Skin                                       Nerves  
          Joints                                    Hair follicles and Muscles 
  CLASSIFICATION: 
             Classification of vatha diseases are described by various siddha literatures as seen 
as below 
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S.NO NAMES OF SIDDHA BOOK TYPES 
1. Yugi vaithiya chinthamani  
‘”’ “vd;dNt thje;jhnzz;gjhFk;" 
80 
2. Siddha maruthuvam pothu 85 
3. Agathiyar Guru naadi 235 84 
4. Agathiyar Rathna surukam500  
  “kw;wNk thjNuhfk; tifvz;gJ ehNy"”” 
84 
5. Astanga sangiragam 85 
6. Agathiyar 2000 
    “Vz;gJ thjkhF kpUtifg; gLj;jpf;fhzpd; 
    ez;GW miuf;F NkNy ehw;gJ thjkhFk; 
    gz; Nruiuf;F fPNo gj;J ehd;fhF nkd;W 
    tz;L Nrh; FoypdhNy thjj;jpd; $WjhNd" 
 
80 
7. Bogar vaithiyam 700 
     “thr; nrd;w thjk; vz;gJTk; NghFk;" 
80 
 
8. Jeeva rakshamirtham 80 
9. Noi nadal and noi muthal nadal part 2 85 
10. Theraiyar vagadam 81 
11. Anuboga deva ragasiyam 84 
12. Thanvanthiri vaithiyam  80 
 
DESCRIPTION OF VATHA: 
                    As per our siddha aspect the first phase of human life is attributed to vatham 
and middle of life is pitham and final phase is kabha kalangal. This is explained by 
following siddha text book is  
“thjkha; gilj;J 
 gpj;j td;dpaha; fhj;J 
 rpNyj;Jk rPjkha; Jilj;J” 
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    -Neha; ehly; Neha; Kjy; ehly; jpul;L ghfk; I  ,  gf;f vz; 97.                                                                                                                                                           
10 types of Vatham are explained below, 
1. PRANAN: 
                   This refers to cardiac plexus in the heart region and controls heart and 
circulation. 
2. ABANAN: 
                  This centre corresponds to the pelvic plexus and is the seat of kundalini or 
material energy and controls excretion. 
3. VIYANAN: 
                  This corresponds to the naso ciliary plexus at the root of the nose and base of 
the skull and controls “will” 
4. UTHANAN: 
                  This corresponds to the pharyngeal plexus in the throat region and controls 
breathing and speech. 
5. SAMANAN: 
                   This responsible for proper digestion and it’s stabilize the other vayus. 
6. NAGAN: 
                   It is responsible for intelligence of the individual, it is responsible for opening 
and closure of eyes. 
7. KOORMAN: 
                   It is responsible for opening and closure of eye lids, yawning, vision, closing 
of mouth. 
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 8. KIRUKARAN: 
        It is responsible for salivation, and nasal secretion. It involves sneezing, cough, 
and stimulate appetite. 
9. DHEVATHATHAN:  
                    It is responsible for laziness, tiredness, arguing, angry. It helps the movements 
of the eyeball and it is present in genital region. 
10. THANANJEYAN: 
                    It is situated in the nose and it leaves from the body through cranium only on 
third day after death.               
VATHA THEGI UDAL: 
                According to siddha maruruthuvanga churukkam is clearly mention the 
following features of vatha thegi ilakanam.  
“thj clypdDf;Fj; jPAk; IaKk; Fiwe;J tsp kpFe;jpUg;gJkd;wp> 
nkype;J cah;e;j clYk;> gUj;j mbj; njhilfSk;> ele;jhy; fPy;fs; 
nel;ilapLjYk;> jbj;j ,ikfSld; tl;lkhf tpfhhpj;Jr; rhf;fz; Nghd;W 
RuRug;ghAk;> rpwpJ ntz;ik fye;jdthAkpUf;Fk; fz;fSk;> Fsph;e;j 
ghh;itAk;> rpwpJ fWik ntz;ik fye;jdthAkpUf;Fk; fz;fSk;> rpwpJ 
ntz;ik fye;J xspUk; cly; epwKk; mt;thW fWj;J Kid gpse;j jiy 
kapUk;> njspthd thh;j;ijiaAk; rpy Ntis kdf;fyf;fj;Jld; gl;Lk;  
glhikAkhd jLkhw;w thh;j;ijAk;> jpj;jpg;G Gspg;G> cg;G> #L cs;s 
nghUs;fspy; rpwpJ tpUg;gKk;> Fsph;r;rp nghUe;jpa nghUs;fspy; ntWg;Gk;> 
kpf;f cz;bAk;> kpf;f cz;bnadpDk; mw;g td;ikAk;> ngz;fsplj;jpy; mw;g 
tpUg;Gk;> tPhpa tsh;r;rpf; FiwTk;> Gj;jpu ngUf;fKk;> Mz;ik czh;r;rp 
mwpT ,it epiyapd;ikAk;> tpisahl;L> ,ir mtkjpr;rphpg;G> njhf;fzk;> 
Ntl;ilahlypy; tpUg;Gk;> jFjp ,d;ik> gifik> <ifapd;ik> nghd;dhyhd 
nghUs;fis fth;jypy; epidg;G Kjypa gz;GfSk; Gfopd;ikAk;> 
miuf;fz; %ba rpW J}f;fKk;> mj;J}f;fj;jpy; tpz;> kiy> fhL ,itfspy; 
jhd; elg;gjhff; fhZfpd;w fdTk;> Gyikj; jpwikiaAk; cz;lhapUf;Fk;.” 
                             -rpj;j kUj;Jthq;fr; RUf;fk; , gf;f vz; 170 
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jz;lfthjk; 
DEFINITION: 
                  T.V.SAMBASIVAMPILLAI AGARATHI is clearly mentioned about its 
definition. 
        mtatq;fis nraywr; nra;J clk;ig jz;lj;ijg; Nghy; tPo;j;jp 
ePl;ly;, klf;fy;, mirj;jy; Kjypait ,y;yhky; rtj;ijg; Nghy; fplf;fr; nra;Ak; 
thj NehahFk;. 
                                 -T.V.rhk;grptk;gps;is mfuhjp ghfk; IV 
AETIOLOGY: 
                  The aetiological factors which exaggerate vatha diseases are explained by 
siddha literatures. These are as follows, 
According to YUGI MUNIVAR IN YUGI VAIDHIYA CHINDHAMANI 800:- 
              “vd;dNt thje;jh ndz;gjhFk; 
      ,fj;jpNy kdpjh;fSf; nfa;AkhW 
       gpd;dNt ngz;jidNa NrhuQ;nra;J 
      nghpNahu;fs; gpuhkziuj; J}lzpj;;Jk; 
       td;d Njtr; nrhj;jpy; NrhuQ;nra;J 
      khjhgpjh FUit kwe;j Ngh;f;Fk; 
       fd;;dNt Ntjj;ij epe;;ij nra;jhy; 
      fhaj;jpw; fye;jpLNk thje;jhNd.””””’”” 
                      -  A+fp itj;jpa  rpe;jhkzp - ghly; 243 
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  Breach of  Trust. 
 Abusing the elderly people, the priests and also the holy spirits. 
  Exploitation of charitable properties. 
  Ingratitude towards mother, father and teacher. 
“jhndd;w frg;NghL Jtu;g; Giwg;G 
rhjfkha; kpQ;RfpYk;  rikj;j td;dk; 
Mndd;;w thwpdJ Grpj;j yhYk; 
Mfhaj; NjwyJ Fbj;;jyhYk; 
ghndd;w gfYwf;f kpuhtpopg;G 
gl;bdpNa kpfTWjy; ghu nka;jy; 
Njndd;w nkhopahh; Nkw;rpe;ij ahjy; 
rPf;fpukha; thjkJ nrdpf;Fe; jhNd.”” 
                      -A+fp itj;jpa rpe;jhkzp - ghly; 244 
  Excessive intake of bitter foods, astringent foods and pungent foods. 
  Intake of dry and old cooked rice. 
  Drinking raw rain water. 
  Sleeping during day time and keeping awake during night. 
  Undue starving. 
  Lifting of heavy loads and sexual Perceptions. 
“Mdhd tud;widNa kjpahkhe;;jh; 
Mfjp guNjrpah;fl; fd;d kPPahh; 
Nfhdhd FUnkhopia kwe;j Ngh;fs;  
nfhiy fsT ngha;fhkq; Fwpj;j Ngh;f;F 
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Cdhd rle;jd;dpy; thjk; te;J 
cw;gtpf;Fk; Ntjj;jpd; cz;ikjhNd. ” 
                                   -A+fp itj;jpa rpe;jhkzp - ghly; 253 
  Disobedient attitude towards God. 
  Refusing food for destitute to poor people. 
  Disregarding the advice of priests. 
  Engaging in murder. 
  Stealing.  
  Lieing. 
“gfuNt thjkJ Nfhgpj; jg;Ngh 
gz;ghf ];jphP Nfh\;baJ jhd; nra;apy; 
efuNt ntFJ}utop elf;fpy; 
espuhd fhw;WNk gdpNkw; gl;lhy; 
kpfuNt fha;fs; fdpfpoq;F jd;id 
kpftUe;;jp kPwpNa japh;;jhd; nfhz;lhy; 
KfuNt KJnfYk;ig KWf;fp nehe;J 
Koq;fhYk; fizf;fhYk; fLg;G cz;lhNk”” 
                               -A+fp itj;jpa rpe;jhkzp - ghly; 285 
 Including in sexual act during the abnormally increased condition of vatham. 
  Walking for a long distance. 
  Exposure to chillness. 
 Excessive consumption of Rhizomes, fruits, curd, etc. 
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ACCORDING TO AGASTHIYAR NAADI:- 
            “nrhy;yNt thjkJ kPwpw;;whdhy; 
     Nrhh;tile;J thAtpdhy; Njfnkq;Fk; 
      nky;y if fhy; fsrjpAz;;lhFk; 
        nka;Klq;Fk; epkpunthz;zhj; jpkpUz;lhFk;." 
                                        -mfj;jpah; ehb 
 Weakness of the limbs 
 Stiffness of joints and Numbness 
ACCORDING TO AGASTHIYAR KANMA KANDAM – 300: 
               In siddha system, many diseases are to be precipitated by kanma, which means 
the deeds good or bad committed by an individual in his previous and present births. The 
Genetic dispositions of certain diseases are probably the result of kanma. According to the 
below verse, vatha disease may also be precipitated by kanma. 
  “E}nyd;w thjk; te;jtif jhNd 
        Ez;ikaha;f; fd;kj;jpd; tifiaf; NfS 
       fhypNy Njhd;wpaJ fLg;g NjJ 
        iffhypy; Klf;fpaJ tPf;fNkJ 
       NfhypNy gLfpd;w tpUl;r khd 
        Foe;ij kue;jd;id ntl;ly;N;ky; Njhy;rPty; 
       ehypNy rPtnre;J  fhy; Kwpj;jy; 
         ey;y nfhg;G jio Kwpj;jy; eypj;jy; jhNd. " 
- mfj;jpah; fd;k fhz;lk; ghly; vz; 56 
14 
 
ACCORDING TO THERAIYAR VAAGADAM: 
“thjtPW md;dkpwq;fhJ fLg;Gz;lhk; tz;z Kz;lhk; 
NkhJ fl;L; Nuhfk; Ru Kz;lh kpUkYkp Kwq;fh njd;Wk; 
XJ #hpa thjkdyhF eLf;f Kz;lhk; nghUs; fsha;j; 
jPnjdNt euk; gprpj;J re;Jfs; NjhWk; fpLf;Fe; jhNd. " 
                                           - Njiuah; thflk; 
  Loss of appetite 
  Backache 
  Fever 
  Cough 
  Sleeplessness 
  Shivering and pain in joints 
“jf;f thA Nfhgpj;jhy; re;J Tise;J jiyNehth 
kpf;f %up nfhl;;lhtp tpl;lq; nfhpA kyq;fl;L;;k; 
xf;;f euk;G jhd;Klq;F Kyh;e;J tha; ePUwptUk; 
kpf;f FspUk; eLf;fKkhk; Nkdp Fd;wp tUq;fhNz." 
                              - Njiuah; thflk; ghly; vz; 42 
 
  Painful joints 
  Headache 
  Excessive yawning 
  Constipation 
  Burning sensation of the body 
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  Excessive salivation 
 Tremors 
ACCORDING TO SIKITCHA RATHNA DEEPAM: 
“thjj;jpd; FzNk jd;dpy; kaq;Fe;jpnaq;Fk; kyh; rptf;Fk; 
ghjq;  Fsph;e;;J rUthq;;fk; gw;;wpelf;F Kfq; fLf;;FQ; 
rPjj;;JlNd tapW Gz;;zhQ; rphpg;;gpj;Je; njwp %r;;rhk; 
Nghjj; jz;zPh; jhd;thq;Fk; GfOk; gQ;r FzkhNk.”” 
“thjNk fjpj;j NghJ that nkOk;Gq; fz;Bh; 
thjNk fjpj;j NghJ that te;jpLQ; rd;dp Njhrk; 
thjNk fjpj;j NghJ te;jpLk; tpahjp NkYk; 
thjNk fjpj;j NghJ ty;Yly; nkype;J nfhy;Yk;.” 
 
  Giddiness 
 Chillness in the lower extremities 
  Excessive thirst 
  Pain in the face. 
ACCORDING TO AGATHIYAR 2000: 
“thjj;jpd; Fzj;ijf; Nfz;kpd; tapW}Jk; nghUkpf; nfhs;Sk; 
jhJ}w;w clk;;G iffhy; re;Jfs; fLg;Gj; Njhd;Wk; 
jPJw;w rpWePh; jhDQ; rpte;;Jly; fLj;J tpOk; 
NghJs;s Tg;Grkha; NghjTk; grpj;jplhNj”” 
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“fhy;if fLf;Fk; jpkpUz;lhq; fz;;Ze; J}q;fpr; Nrhgpf;;Fk; 
Nfhyq; nrupA kq;f nky;yhq; Fsph;e;J re;J fdq;;nfhs;Sk; 
rpy kpFe;J rPh; fhzpy; rpWePh; tw;wp tUkpfNt 
kyj;jlq;fz; khd idaha; khj thj NuhfkpNj” 
         -mfj;jpah; 2000 
When vatham is increased it causes, 
  Flatulence 
  Burning pain in the upper and lower extremities 
  Burning and scanty micturition 
  Loss of appetite 
  Numbness in the limbs 
ACCORDING TO PARARASA SEKARAM: 
                    “ghhpdpw; gag;gl;lhYk; gyUld; Nfhgpj;jhYk; 
            fhnudf; fUfpNahbf; fOkuj;J uj;jpdhYk; 
         Vh;ngW jdJ neQ;rpd; kpfj;Jf;f kile;jpl;lhYk; 
             ghhpa fhw;wpdhYk; glhPDk; thjq;fhZk;”” 
 Fear 
 Angry 
 Stress 
 Exposure to cool Air 
ACCORDING TO AGATHIYAR GUNAVAGADAM: 
                       “tptuklh mrjp rd;dp %is NehT 
             tphpthd %isaJ kpUJthfp 
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          mtdpjdpy; jplkhfg; NghtjhYk; 
             mg;gNd %j;jpu Fz;bf;fha; tpahjpahYk; 
          jtKdpth; jPh;f;fhf;if Nkf Nuhfk; 
             jd;ikAs;s Kj;jz;L nfhbtpahjp 
          mtkpyhg; ghpr euk;gOj;jq; fz;lhy; 
             mZFklh thjNeha; MFk;ghNu.” 
 
 Brain and kidney diseases, 
 Megaroga Nithanam, 
 Connective tissue diseases , 
SIGNS AND SYMPTOMS: 
                        Vatham is the major vital force of body. It is formed by the combination of 
vayu (wind) and agayam (sky). It spreads all over body. Thandagavatham is one among 
the 80 types of vatha diseases. Signs and symptoms of Thandaga vatham is explained by 
various siddha text as follows  
ACCORDING TO YUGI VAITHIYA CHINTHAMANI 800: 
             “tOj;jNt %yhjhuj;ijg; gw;wpNa 
             kUtpNa NkNywp KJFz;lhjy; 
      tpOj;jNt rpurpy; te;J tpah;Tkhfp 
             tpFthf Nehthfp Nkdp fd;dp 
      gj;jNt clk;ngq;Fk; gQ;R Nghyhk; 
             ghq;fhd  kyry kQ;rshFk; 
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      FOj;jNt njz;lkhk; thje;jd;idf; 
             $wpNdhq; Fznky;yhq; $h;e;J ghNu”  
        -A+fp itj;jpa rpe;jhkzp ghly; 288 
           “$h;e;jpl;l kyryq;fs; Jhpjkhdhy; 
             nfhz;l lf;fpg; gpd;Gjhd; nfhbjha; js;sp 
      Ch;e;jpl;l rhPuj;jp Yjpu kPwp 
  cwj; Njaj;J jiyajdp nyz;nza; thh;f;fpy; 
thh;j;jpl;l top elf;fpy; nkj;j te;jhd; 
  thje; jhDw;gtpj;J eil nfhlhky; 
ehh;e;jpl;l euk;NghL vYk;gpw; #o;e;J 
  eZfpNa Nahb neQ;rp NtWe; jhNd;” 
-A+fp itj;jpa rpe;jhkzp ghly; 289 
     Nahfj;jpd; Kjy; epiyapy; EioAk; NghJ cz;lhFk; Nfl;lhy;> 
KJFj;jz;bd; fPo;g;Gw kpUe;J jiy tiuapYk; fpsk;gpa thAtpdhy; 
Vw;gLk;NehahFk;. ,e;Nehapy; tpah;j;jy;> cly; ,WFjy;> typj;jy;> cly; gOj;Jg; 
gQ;RNghy; ntSj;jy;> kyKk; rpWePUk; kQ;rshjy; vd;Dk; Fwp 
Fzq;fisf;fhl;Lk;. 
     jz;lf thAtpYz;lhFk; fopr;riy mlf;fp tUtjyhy; rpd;dhl;fs;nrd;w 
gpd;G mf;fopr;ry; mlf;f Kbahj mstpy; kpFe;J fopaj; njhlq;Fk; mjdhy; 
cly; KOikAs;s FUjp jd;dstpy; kpFe;J ghAk;. md;wpAk; ,e;Neha; KOikAk; 
NghfhjpUf;ifapy; jiy KOfy;> mjpfj; njhiyTelj;jy; ,tw;iw Nkw;nfhs;spy; 
tspf;Fw;wk; kpFe;J euk;G> vYk;Gfisg; gw;wpr;#o;e;J elf;f Kbahkw; nra;J 
mt;thA neQ;R tiuAk; ghAk;. 
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ACCORDING TO THANVANTHIRI VAITHIYAM: 
                  “Mkfl;ljdhy; thA tjpfkha;r;;rpNyw; gdj;ijj; 
         J}kfl;lhfr; Nrh;j;Jj; jbj;jpLQ;; rhPu nky;yhk; 
         Nehkf; fl;lhd Nkdp Etypisg; ngah;g;Gj; Njhd;Wk; 
         jhkf; fl;lhd Nuhfe; jz;lf thjkhNk”” 
                                    -jd;te;;jphp itj;jpak; 
Mkj;Jld; thA mjpfhpj;J fgj;Jld; Nrh;e;J rhPuj;ij ];J}ypf;fr;nra;Ak;. rhPuk; 
thl;lkilAk;. 
  Generalized odema 
  General weakness 
ACCORDING TO ROGANIRNAYA SARAM: 
          “Njfk; jz;lj;ijg; Nghy; tpOe;J mirtpy;yhky; ,Uf;Fk;” 
            -Nuhf eph;za rhuk; 
 Body is rendered like a log of wood. 
ACCORDING TO JEEVA RATCHAMIRTHAM:- 
         “thAthdJ vz;nza; t];J> ke;jt];J> rPu tPhpa t];J> japh;> 
mjpfytzk;> gfy; epj;jpiu> gjpdhd;F Ntfq;fis kwpj;jy; Mfpatw;why; gpwe;J 
rg;jjhJf;fspYk; tpahgpj;J mitfisf; fiyj;Jtpl;L Mkhra];jhdj;ij 
mDrhpj;Jr; rpNyj;k gpj;jq;fisj; jd;Dld; Nrh;j;Jf; nfhz;L mtatq;fspd; 
nraiy khw;wptpLk;. ,jdhy; urhjp jhJf;fspy; kuj;jy;>rPjsk;> cs;nshpr;ry;> rhPuq; 
fdj;jy;> Qhgfkwjp> gpuik> Royy; NghypUj;jy;> ,isg;G> mjpf Ntjid> ePh;f;fl;L 
vd;Dk; ,f;FwpFzq;fNshL NjfkhdJ jz;lj;ijg; Nghy tpOe;J mirjYk; 
ePl;ly; Kf;fYk; vOjYk; ,y;yhjpUf;Fk;. 
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 ,J Njfj;ij jz;ilg; Nghy ePl;b tpLjyhy; jz;lf thjk; vdg;Ngh;ngw;wJ.” 
         -mDNghf itj;jpa Njtufrpak; (Kjy; ghfk;) ,  gf;f vz; 164 
  Numbness 
  Burning sensation 
  Loss of memory 
  Giddiness 
  Dyspnea 
  Body pain 
  Anuria 
  Body is rendered like a log of wood 
ACCORDING TO SIKITCHARATHNADEEPAM:- 
 thAthdJ %yhjhuj;ijg; gw;wp NkNywp KJfpypUe;J rpurp;y; te;J tpah;j;J 
NehAz;lhf;fp rh;thq;fj;ijAk; NehAwr; nra;tJld; kyryk; kQ;rs; th;zkhfTk; 
Njfj;ij jz;lfk; Nghy; ePl;l tplhky; nra;Ak;. 
                                    -rpfpr;rh uj;d jPgk; 
 Yellow colour faeces 
 Yellow colour urine 
 Body is rendered like a log of wood 
PATHOPHYSIOLOGY: 
              According to Theraiyar  ,   
                                  “thjkhyhJ Nkdp nflhJ" 
             Vatham is the initiator of all forms of activity .The primary factor affected first is 
vatham and followed by pitham and kabam. The alteration of vatham is due to irregular 
diet, physical activities, seasonal variations, which may be reduced or exaggerated the 
vatham. It produce disturbances of other dosha. 
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FOOD VARIATIONS: 
         “GspJth; tpQ;Rq;fwp ahw;G+hpf; Fk;thjk; 
          xspAth; ifg;Ngwpy; gpj;JQ;rPWk;-fpspnkhopNa 
          fhh;g;gpzpg;G tpQ;rpw; fgk; tpQ;RQ; rl;bujr; 
          Nrug; Gzh; NehaZfhNj””        
                  Neha; ehly; Neha; Kjy; ehly; ghfk; 1 
                                                      gf;f vz; 23                                                                                   
    Sour and astringent increases vatham. 
    Salt and bitter increases pitham. 
    Pungent and sweet increases kabham. 
ENVIRONMENTAL FACTORS: 
     People who are living places can produce the following diseases. Thinai is classified 
into 5 types  
 Kurinji              -      Kaba noigal 
 Mullai               -     Pitha noigal 
 Marutham         -     No diseases will occur 
 Neithal              -     Vatha noigal 
 Paalai                -     Mukkutra noigal  
SEASONAL VARIATIONS:  
         Seasons are classified into 6 types. 
        Kar, Koothir, Munpani, Pinpani, Ilavenil, Muthuvenil 
        Seasonal variations are produce alteration in the three humours. 
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HUMOUR 
THANNILAI 
VALARCHI 
PIRANILAI 
VALARCHI 
 
NORMAL 
Vatham  Muthuvenil   Kaarkalam  Koodhir kalam 
Pitham  Kaar kalam  Koodhir kalam Munpani kalam 
Kabham  Pinpani  Ilavenil  Mudhuvenil  
 
          Uyir thathukal and udal thathukal get affected it may produce vatha diseases. Any 
defect in uyir thathukal it may produce derangement in udalthathukal. These are explained 
below 
CHANGES OF UYIRTHATHUKAL IN THANDAGA VATHAM: 
                  Vatham, pitham, kabam is called as Uyir thathukal. There are several changes 
are involved in Thandaga vatham is described below          
VATHAM: 
 
S l. 
NO 
 
VATHAM 
 
LOCATION 
 
FUNCTION 
 
THANDAGA 
VATHAM 
1. Pranan  Chest region  Regulate respiration and 
controls  the mental  functions,   
functions of heart, lungs and 
brain  
Not affected 
2. Abanan Pelvic region Control excretion such as 
sweating evacuation of stools, 
ejaculation of sperms, 
micturition, menstruation and 
parturition.  
May affected 
3.  Viyanan Nose and skull Helps in various movements of 
the body and responsible for 
nervous functions and sensation. 
Affected 
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4. Uthanan Throat Responsible for speech, 
vomiting hiccough, cough. 
Not affected 
5. Samanan Navel  Regulates the digestion and 
controls all the other vayus. 
affected 
6. Nagan Eyes  Helps in opening and closing of 
the eyes, intelligence. 
Not affected 
7. Koorman  Eyes  Responsible for vision, closure 
of eyelids 
Not affected 
8. Kirukaran Saliva  Secretion of saliva and mucous 
secretion in nasal cavity, helps 
concentration 
Not affected 
9. Devathathan Ocular 
muscles  
 It is responsible for laziness 
and  eyeball movements 
May affected 
10 Thananjeyan -  It is responsible for  
degradation of body after death 
- 
 
CHANGES OF PITHAM IN THANDAGA VATHAM: 
 
 
Sl.NO 
 
PITHAM 
 
FUNCTIONS 
THANDAGA 
VATHAM 
1. Analagam Digestion Not affected 
2. Ranjagam Gives nutrition to blood Not affected 
3. Sathagam 
Responsible for willful 
Activities 
Affected 
4. Prasagam Gives luster to skin Not affected 
5. Alosagam Gives strength to eyes No affected 
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CHANGES OF KABHAM IN THANDAGA VATHAM: 
 
S.NO 
 
KABHAM 
 
FUNCTIONS 
THANDAGA 
VATHAM 
1. Avalambagam Controls other kabam. Not affected 
2. Klethagam It Lubricates the Food. Not affected 
3. Pothagam   Responsible for  
Taste sensation 
Not affected 
4. Tharpagam   It acts as coolent  for eyes Not affected 
5.  Santhigam  It maintains the  
Integrity of joints  
Affected 
 
CHANGES OF UDAL THATHUKAL: 
Sl. 
No 
UDAL 
THATHUKAL 
FUNCTIONS 
THANDAGA 
VATHAM 
1. Saram Strengthens the body and mind Affected when 
Tiredness of body  
2. Senneer Preserves brightness, boldness, 
Power, knowledge  
Affected when anemia 
present 
3. Oon Gives structure and shape to body   Muscle wasting  
4. Kozhuppu Lubricates the joints Restricted movements 
in joints 
5. Enbu Physical  Structure Produces Degeneration 
In lumbar vertebra and 
osteophytic changes  
6. Moolai Strengthens the bone Affected 
7. Sukkilam/Suronitham Reproduction  Not affected 
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PINIYARIMURAIMAI (DIAGNOSIS):  
              Diagnosis is very important because it is helpful for correct treatment. In siddha 
system of medicine have 4 diagnostic tools.  
 1. PORIYAL ARIDHAL: 
                     The physician should examine the patient by Imporigal. 
 Mei                -          Sensations 
 Vai                  -         Taste 
 Kan                 -         Vision 
 Mooku           -         Smell  
 Sevi                 -        Hearing 
 2. PULANAL ARIDHAL: 
                     The physician should examined the patient by Impulangal 
 Suvai                 
 Oli                   
 Ooru  
 Osai 
 Natram  
3. VINADHAL: 
               Vinadhal means asking questions to patients for diagnostic purpose. So only 
history taking is important for treatment. Sometimes patient having the unconscious or 
unable to speak condition the history is taken from neibours. 
4. ENVAGAI THERVUGAL:  
                Envagai Thervugal is one of the diagnostic tool in siddha system. 
  According to Noi Nadal Noi Mudhal Nadal part 1, 
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    “ehbg;ghprk; ehepwk; nkhoptpop 
     kyk; %j;jpukpit kUj;JtuhAjk;" 
According to Theraiyar, 
     “nka;f;Fwp epwe;njhdp tpopehtpUkyk; iff;Fwp" 
  The diagnosis is made by following types  
              1. Naadi 
              2. Sparisam   
              3. Naa  
              4. Niram 
              5. Mozhi 
              6. Vizhi 
              7. Malam 
              8. Moothiram 
            This Envagai Thervugal is described below.  
1. NAADI: 
             Naadi is defined as Uyirthathu. The combination of   three Uyir vayukkal and three 
Thasanadigal is forms 
Uyirthathukal. 
THASA NADIGAL UYIR VAYUKKAL HUMOURS 
Idakalai Abanan Vatham 
Pinkalai Pranan Pitham 
Suzhimunai Samanan Kabham 
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   This can be felt in one inch below the wrist on the radial side by using index, middle 
and ring fingers this indicates vatham, pitham and kabham respectively. 
ehbfspd; khj;jpiu msT: 
                           “nka;asT thjnkhd;W 
             Nky;gpj;jNkhuiuahk; 
  Iaq;fhnyd;Nw mwp” 
                      -fz;Zrhkpak; 
 Vatham   1    mathirai. 
 Pitham     ½   mathirai 
Kabam     ¼    mathirai 
   Any derangement in this ratio leads to diseases. 
2. SPARISAM: 
              Through sparisam to know the temperature either heat or cold, smoothness, 
roughness, sweat, dryness of skin, patches, swelling, abnormal growth, ulcer, pain can be 
felt. 
3. NAA: 
               To examine the colour, deviation, dryness, coating, ulceration, movements, taste 
variations, condition of teeth and gum. 
4. NIRAM: 
                  To examine the colour changes in the conjunctiva, nails, skin, tongue, teeth, 
hairs. 
5. MOZHI: 
                To assess the mode of speech, quality of sound (low or high pitch)   
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6. VIZHI: 
             To examine the discolouration, structure and shape of eye, and any discharge in 
eye is also noted. 
7. MALAM: 
         By the examination of Malam to know the nature (solid, semisolid, liquid), colour, 
quantity, presence of blood, mucous can be noted. 
8. MOOTHIRAM: 
            The examination of Moothiram involved 2 types, 
         1. Neerkuri  
         2. Neikuri 
 1. NEERKURI: 
         According to siddha maruthuvanga surukkam neerkuri is explained by    
              “te;jePh; fhp vil kzk; Eiu vQ;rnyd; 
               iwe;jpa Ysit aiwFJ KiwNa" 
                                                                                          -rpj;j kUj;Jthq;fr; RUf;fk; 
                                                  gf;f vz; 510 
                   Examination of neerkuri include 5 findings there are 
i) NIRAM 
It means colour of urine that is yellow, red, green and black. 
ii) MANAM 
           It means smell of urine, such as pleasant, foul smelling, fish odour, fruit, honey 
smell. 
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iii) NURAI 
It means frothy nature of urine. 
iv) EDAI 
Edai means specific gravity of urine. 
v) ENJAL 
            It indicates the deposits in urine such as crystals, salts. 
2. NEIKURI: 
‘  “epwf;Fwpf; Fiuj;j epUkhz ePhpw; 
    rpwf;f ntz;nza;Nahh; rpWJsp eLtpLj; 
    njd;Wwj; jpwe;njhyp Vfhjikj;jjp 
    dpd;wjptiy Nghk; newptpopawpTk; 
    nrd;wJ GfYQ; nra;jpia AzNu” 
 
(nghUs;) ePh; epwf;Fwpahy; Nehiaf; fz;L gpbj;jw; nghUl;Lr; 
nrhy;ypapUf;fpd;w tpjp nghUe;jpa rpW ePhpy; xU rpwpa Jsp vz;nzia eLtpy; 
ifairtpdhy; vz;nza;j; Jsp rpjwhky; tpl;L nta;apyhdJ me;ePhpy; gLk;gb 
jpwe;J fhw;whdJ mjpy; tPrp me;j vz;nza;j; Jsp Mlhjgb itj;J mr;rpW 
ePhpy; tplg;gl;bUf;fpd;w vz;nza;j; JspahdJ nry;Yfpd;w topapy; 
fz;zwpitAk; capuwpitAk; nrYj;jp mj;Jsp njhptpf;Fk; Neha; tpsf;fj;ij  
eP njhpe;J nfhs;thahf. 
 
A drop of gingili oil in to the center of the upper surface of urine, if the oil spreads like  
 Snake like appearance indicates Vatham 
 Ring like appearance indicates Pitham 
 Pearl like appearance indicates Kabham 
 Mixed reaction indicates Thontham 
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 DIFFERENTIAL DIAGNOSIS: 
                              The clinical features of Thandaga Vatham is similar to some other 
vatha diseases. 
They are 
1. Aasuva thamba vatham 
2. Oorusthamba vatham 
 
1. MRtjk;g thjk; : 
‘           “thjkh Aly;ntSj;J tonty;  yhNeuk; 
             kaf;fNkh bUkyh A+is Az;lhk; 
             Nejkha; neQ;rilj;jg; nghwp fyq;Fk; 
             neUg;ghf cly;fhZ neL%r;Rz;lhk; 
             NfhJjhd; kaf;fj;jpy; kUe;jp ePl;lhy; 
             Fsph;r;rpaha;f; Nfhgpf;Fq; $r;rYz;lhk; 
             Ghje;jhd; jpkpUzlha; Kl;N;ghyhFk; 
             gLj;j MRtjk;gk; gfuyhNk” 
                                           -A+.fp.itj;jpa rpe;jhkzp 
 
The Clinical features are: 
1. Paleness of the body 
2. Cough 
3. Chest heaviness 
4. Numbness of both lower limbs. 
5. Pain present in vertebral column 
 
2. CUj;jk;g thjk;: 
‘             “Mnkd;w thjkJ cs;s lq;fp 
                mbj;Jiljhd; Fwq;fpuz;L kstha;g; gw;wp 
                fhnkdw; iffhypy; tpuY Rw;wpf; 
                fdj;JNk rhzpaJ nghjpe;jhh; Nghyj; 
                Njnkd;w rpue;jdpNy ghu Kz;lha;j; 
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                Njnkq;F %jpNa jpkpUz;lhFk; 
                ehnkd;w elf;nfhzu nthLf;f khfp 
                eypA+Ue; jk;gkJ eDFq;fhNd”” 
 
The clinical features are 
1. Heaviness in both thighs 
2. Feelings of cow waste applied over fingers of both hands and feet 
3. Numbness feel in whole body 
4. Difficulty in walking. 
                  In Thandaga Vatham   diffuse low back pain, stiffness, radiating pain to lower 
limbs, yellow coloured urine and stools are present. 
Modern Aspects
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MORDERN ASPECT 
 
INTRODUCTION 
 
        The vertebral column is also called the spine, the spinal column or back bone. It 
is the central axis of the body. It supports the body weight and transmits it to the ground 
through the lower limbs. 
The vertebral column is made up of 33 vertebrae. 
Cervical  -  7  
Thoracic  -  12 
Lumbar  -  5 
Sacral   -    5 
Coccygeal  -    4 
     In the thoracic, lumbar and sacral region the number of vertebrae corresponds to 
the spinal nerve, each nerve lying below the corresponding vertebra. In the cervical 
region there are eight nerves the upper seven lying above the corresponding vertebrae and 
eighth below the seventh vertebra. In the coccygeal region there is only coccygeal nerve.                             
The length of the spine is about 70 cm in Males and 60 cm in Females. 
  The Intervertebral discs contribute one fifth of the length of the vertebral column. 
 
CURVATURES OF THE VERTEBRAL COLUMN 
 
IN SAGITTAL PLANE: 
 
1. Primary curves are present at birth and due to the shape of the vertebral 
bodies. The primary curves are thoracic and sacral both of which are concave 
forwards. 
2. Secondary curves are postural and are mainly due to the shape of the 
intervertebral disc. The secondary or compensatory curves are cervical and 
lumbar both of which are convex forwards. The cervical curve appear during 
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four to five months after birth when the infant starts supporting its head.  
The lumbar curve appears during twelve to eighteen months when the child 
assumes the upright posture. 
 
IN CORONAL PLANE (LATERAL CURVE): 
       There is slight lateral curve in the thoracic region with its concavity towards the 
left. It is possible due to the greater use of the right upper limb and the pressure of the 
aorta. 
 
INTERVERTEBRAL JOINTS: 
Adjoining vertebrae are connected to each other at three joints. There is a median 
joint between the vertebral bodies and two joints right and left between the articular 
processes. 
        The joints between the articular processes are plane synovial joints. 
        The joint between the vertebral bodies is a symphysis. The surfaces of the 
vertebral bodies are lined by thin layers of hyaline cartilage. Between these layers of 
hyaline cartilage there is a thick plate of fibrocartilage which is called the intervertebral 
disc. 
 
INTERVERTEBRAL DISCS: 
These are fibrocartilaginous discs which intervene between the bodies of adjacent 
vertebrae and bind them together. Their shape corresponds to that of the vertebral bodies 
between which they are placed. The thickness of the disc varies in different regions of the 
vertebral column, and in different parts of the same disc. In the cervical and lumbar 
regions the discs are thicker in front than behind, while in the thoracic region they are of 
uniform thickness. The discs are thinnest in the upper thoracic region and thickest in the 
lumbar region. 
The discs contribute about one – fifth of the length of the vertebral column. The 
contribution is greater in the cervical and lumbar regions than in the thoracic region.  
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Each disc is made up of the following two parts: 
1. Nucleus Pulposus is the central part of the disc. It is soft and gelatinous at birth. 
It is kept under tension and acts as a hydraulic shock absorber. With advancing 
age the elasticity of the disc is much reduced. 
 
    2. Annulus Fibrosus forms the peripheral part of the disc. It is made up of a 
narrower outer zone of collagenous fibres and a wider inner zone of fibrocartilage. The 
fibres from laminae that are arranged in the form of incomplete rings. The rings are 
connected by strong fibrous bands. The outer collagenous fibres blend with the anterior 
and posterior longitudinal ligaments. 
 
LIGAMENTS OF VERTEBRAL COLUMN: 
 Apart from the intervertebral discs and the capsules around the joints between the 
articular processes, adjacent vertebrae are connected by several ligaments which are as 
follows 
1. Anterior longitudinal ligament 
2. Posterior longitudinal ligament 
3. Intertransverse ligaments  
4. Interspinous ligaments 
5. Supraspinous ligaments 
6. Ligamentum flava 
 
MOVEMENTS OF VERTEBRAL COLUMN: 
 The movements are those of  
1. Flexion 
2. Extension 
3. Lateral Flexion 
4. Rotation 
Flexion and Extension occur freely in the cervical and lumbar region, But not 
in the thoracic region. Rotation is free in the thoracic region and restricted in the 
lumbar and cervical region. 
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FUNCTIONS: 
 Inter vertebral discs give shape to the vertebral column. 
 They act as a remarkable series of shock absorbers or buffers. 
 Because of their elasticity they allow slight movement of vertebral 
bodies on each other, more so in the cervical and lumbar regions.  
 When the slight movements at individual discs are added together 
they become considerable.  
 
LUMBAR VERTEBRAE: 
 5 in number which occupy the region of loin. 
        Distinguishing Points: 
 Big size of body. 
 Absence of costal facets on body. 
 Absence of foramen transversarium. 
Only 5th lumbar vertebra presents some special features. The rest are known as 
Typical Lumbar Vertebrae. 
 
TYPICAL LUMBAR VERTEBRAE: 
 Body is large in size deeper in front and behind. Transverse measurement 
is more than antero-posterior measurement. 
 Vertebral Foramen is triangular in shape. 
 Pedicles are short and strong. 
 Laminae is short, strong and broad. It gives attachment to ligamentum 
flava. 
 Spine is Quadrangular in shape. 
 Superior articular processes - its articular facets are slightly concave and 
face backwards and medially. 
 Inferior articular processes - its articular facets are slightly convex and 
face forwards and laterally. 
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FIFTH LUMBAR VERTEBRAE: 
 Body is very large and its anterior part is thicker than posterior part. 
 Spine is small in size. Its upper border is rounded and down turned at its dorsal 
part. 
 Transverse process is massive and stout.  It arises mainly from the pedicle and 
encroaches on to the body. 
 
BLOOD SUPPLY OF THE VERTEBRAL COLUMN: 
 The segmental arteries supply the vertebral and the longitudinal muscles attached 
to them. The lumbar artery gives multiple small branches to the vertebral bodies.  In 
thoracic and lumbar regions, the muscles receive posterior branches of the intercostal, 
lumbar and the sacral arteries. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SPINE PROBLEMS 
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LUMBAR SPONDYLOSIS 
 Lumbar spondylosis is one of the most Common Problem faced by most of the 
people in their day to life. 
DEFINITION: 
 Spondylosis of the lumbar spine means degenerative changes such as 
osteoarthritis of the vertebral joints and degenerating Inter vertebral discs, (Degenerative 
disc disease) in the low back. 
 Lumbar - Low Back Region 
 Spondylo - Vertebra 
 Osis  - Condition 
  It means pathological condition of lumbar vertebrae. 
EPIDEMIOLOGY: 
 Lumbar Spondylosis seen in 85.5% of Population. 
 Disc protrusions affected in 80%  
 Degenerative spinal stenosis affected in 20%. 
 AGE: 
 About 20 Years, 27-37% of Peoples were affected. 
 At the age between 20-29 Years, 10% of Peoples were affected. 
 At the age between 40-50 Years, 80% of Peoples were affected. 
GENDER: 
 Men 84% 
 Women 74% are affected in lumbar spondylosis 
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LOCATION: 
 Lumbar vertebrae is most frequently affected at the level of L4 –S1 levels. 
AETIOLOGY: 
Aetiology for this disorder was explained below  
Degenerative Causes: 
There are primary and secondary causes 
 
a.Primary causes: 
 Genetic Factors 
 Manual Labour 
 Metabolic Factors 
 Senility 
 Vicious attitude 
b.Secondary causes: 
 Osteo arthritis 
 Rheumatoid arthritis 
 Metastatic carcinoma 
 Lymphoma of Spine 
 TB Spine 
 Road accidents  
 Accidental Injury 
 Old Lumbar Fracture 
c. Occupational causes. 
d. Hereditary Factors. 
 Congenital narrowing of the cervical spinal canal (myelopathty is often seen 
when canal’s sagital diameter is 12mm or less). 
 Segemental defects – Hemi vertebra, Fused Vertebra. 
e. Past spine surgery 
f. obesity 
g. smoking – decreases water content in disc 
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l) Acquired narrowing of lumbar spinal canal due to 
 Osteophytes 
 Sacralisation of L5 vertebrae 
 Ossified posterior longitudinal ligament (OPLL) 
 Facet joint hypertrophy (results foraminal stenosis & compression of root of 
radicular artery) 
 Hypertrophied ligamentum flavum (Compress the cord during extension) 
 
PATHOGENESIS: 
 Lumbar Spondylosis is a degenerative disorder that may cause loss of normal 
structure and function. Although aging is the primary cause, the location and rate of 
degeneration is individual. 
 Spondylosis is most commonly found in lowers spine because that is the area of 
the spine that endures the most wear and tear. The lumbar spine holds the majority of the 
body’s weight and is responsible for providing support and stability. 
 The spine is made up of several vertebrae stacked on top of each other. A 
vertebrae is small bone that builds the core structure of spine. On either side of a 
vertebrae is a disc and Joint, both made of soft tissue and sponge like texture to allow the 
vertebra to bend and move.  
 Over time, as the spine undergoes years of repetitive motion, heavy lifting, and 
possible weight gain, the vertebrae of the lumbar spine become compressed and push in 
to the discs and joints from both sides, much like a clamp. This constant pressure can 
cause the discs and joints to gradually deteriorate and possibly develop other spine 
conditions, such as  
 Spinal canal stenosis, 
 Spondylolisthesis, 
 Herniated disc, 
 Disc bulge, 
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 Degenerative disc disease, 
 Bone spurs. 
 This is particularly true in the L5-S1 vertebra because that holds the most weight 
and stability of the body. 
 Another main cause of lumbar spondylosis is arthritis of the spine. Typically, 
Arthritis of the spine develops later in life and contributes to the gradual degeneration of 
the components of the spine. This also could lead to the development of other spine 
conditions, such as bone spurs.  
 Lumbar spondylosis is caused by degenerative changes within the intervertebral 
discs. The soft, elastic material dries out and loses height. Thickening of the ligaments 
that surround the disc occurs. These other ligaments undergo further degenerative 
changes, thickening and potential calcification. Movement stimulates pain fibres in the 
annulus fibrosus and facet joints. Sittting for prolonged periods of time may cause pain 
and other symptoms due to pressure on the lumbar vertebrae. Repititive movements such 
as lifting and bending (eg. Manual labor) may increase pain. 
 Intervertebral discs as people age, certain biochemical changes occur affecting 
tissue found throughout the body.  In the spine, the structure of intervertebral discs 
(Annulus fibrosus, Lamellae, Nucleus Pulposus) may be compromised.  The annulus 
fibrosus (eg.Tire-like) is composed of 60 or more concentric bands of the collagen fiber 
termed lamellae. The nucleus pulposus is a gel like substance inside the intervertebral 
discs encased by annulus fibrosus. Collagen fibers form the nucleus along with water and 
proteoglycans.  
The degenerative effects of aging can weaken the annulus fibrosus structure, 
causing the “Tire tread” to wear or tear.  The water content of the nucleus decreases with 
age affecting its ability to rebound following compression (eg. Shock absorbing quality). 
The structural alterations from degeneration may decrease disc height and increase the 
risk for disc herniation. 
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PATHOPHYSIOLOGY: 
Intervertebral discs are believed to undergo a “degenerative cascade” of three 
overlapping phases. 
 Phase I - Dysfunction Phase 
 Phase II - Instability Phase 
 Phase III - Stabilization Phase 
                 
 Phase I - Dysfunction Phase: 
 Seen between 15 to 45 years of age 
 Circumferential and radial tear seen in the disc annulus 
 Localized synovitis of the facet joints is seen 
Phase II - Instability Phase: 
 Seen between 35 to 70 years of age 
 There is internal disruption of the disc 
 Progressive disc resorbtion takes place 
 Degenerative of facet joint with lax capsules, subluxation and joint 
erosions are seen. 
Phase III - Stabilization Phase: 
 Seen over 60 years of age. 
 Progressive development of hypertrophic bone above the disc and 
facet joints leading to segmental stiffening or frank ankylosis is seen. 
SYMPTOMS OF LUMBAR SPONDYLOSIS: 
Specific conditions that fall under the umbrella term of lumbar spondylosis can 
include herniated discs, bulging discs, bone spurs and osteoarthritis, all of which are 
spinal abnormalities that run the risk of protruding into the spinal canal and exerting 
pressure on spinal nerves. The sciatic nerve is often compressed at the meeting of the 
L5 and S1 vertebrae. Common symptoms of sciatic nerve compression include 
tingling, numbness, weakness and pain that can spread through the following areas: 
 Lower back 
 Radiating pain towards the lower extremities 
 Diffuse tenderness in lumbar bone with limitation of movements 
 Stiffness of lumbar spine 
42  
 Exacerbation of pain on movements 
 Pain increased on forward bending, sneezing, coughing 
 Paraesthesia & sensory loss on affected area 
 Burning and tingling sensation in lower limb 
 Pain and stiffness in low back in the morning hours 
 
Less Common Symptoms: 
 Loss of balance 
 Neurogenic bladder. 
Common clinical syndromes associated with lumbar spondylosis include the following: 
1. LOW BACK ACHE: 
 It’s occurs common in second to fifth decade, disc disease and disc 
herniation occur in 3rd and 4th decade 
 Symptoms of low back pain, radiating to the buttocks and reduced by 
rest and in squatting position 
 Pain Increased while bending forward and sitting, weight lifting, 
coughing etc., 
2. RADICULOPATHY: 
 Sciatica – Pain in supply of sciatic nerve and is regularly due to disc 
herniation 
 It is evidenced by the leg pain, equal to or more than the back pain 
 Pain radiating to lower extremities. 
3. NERVE ROOT COMPRESSION: 
 About 95% of disc prolapse takes place through L4 - L5 region compressing 
L5 nerve root. 
 The other disc prolapse take place through L3 – L4 and L5 - S1, L4 and S1 
respectively. 
 
EXAMINATION:  
          The examination of the lumbar spondylosis is explained below 
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1. INSPECTION: 
Congenital are pathological skeletal deformities like scoliosis, lordosis or kyphosis. 
2. PALPATION: 
 a) TENDERNESS: 
 Scatter tenderness over the low back. 
 Localized tender infilterates of the skin and subcutaneous tissue 
 Palpable tender induration of small intervertebral muscles 
 Tenderness at the level of posterior articulation and pain on 
percussion of affected intervertebral space. 
  b) MOVEMENTS: 
  Movement of the spine 
     i) To test flexion: 
    Instruct the patient to bend forwards as much as possible at the waist.    
Normal flexion is 800 or finger tips 3-4 inches from the floor.  
        ii) Lateral Flexion: 
         Instruct the patient to bend to the left and to the right as far as possible. 
       Normal range is 35
0 
on each side. 
        iii) Extension: 
        Instructs the patient to bend at waist as far backward as possible Normal 
range is 200-300.  
   iv) Rotation:                                                                                                                            
  Instructs the patient to rotate from the waist to the left and to the right as   
far as possible. Normal range is 45
0 
possible. 
All the movements of the spine are tested and found to be controlled in all direction. 
 
3. CLINICAL SIGNS: 
 
 Straight leg raising test (SLR) 
 Braggard’s test 
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 Femoral nerve stretch test 
 Schober’s test 
 Forward bending to touch the toes 
 Flip test 
 Lassegue test 
 Bowstring sign 
 
DIAGNOSIS: 
1. Plain X-ray of Lumbar spine – AP and Lateral views show- altered lordosis. 
 AP view shows any deviation in the longitudinal axis of the vertebral column, 
narrowing disc space 
 Lateral view shows size and shape of the lumbar vertebras, Degeneration in 
facet and uncoverable joints and osteophyte formation 
 Oblique view shows angulation in body of the vertebrae. 
2. Magnetic Resonance Imaging (MRI): 
It shows 
 Any disc degernation in spine 
 Neural compression 
 Detect any intra- spinal lesion 
3. Computerized Tomography (C.T Scan): 
It  
 Confirms the degenerative changes 
 Detect the foraminal structures and lateral disc prolapse 
 Estimate diameter of the vertebral canal segmentally 
 May demonstrate disc herniation and posterior osteophytes 
4. Myelogram: 
Helping in detecting 
 Intra spinal lesion 
 Spinal stenosis 
 Any compression of the spinal cord 
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5. Other Tests: 
 Disco graphy 
 Nerve conduction studies 
 EMG 
DIFFERENTIAL DIAGNOSIS: 
 Osteoporosis 
 Multiple myelomas 
 Multiple sclerosis 
 Extra dural tumour 
 Ankylosis spondylosis 
 Spino vascular insufficiency 
 Peripheral neuropathy 
 Herpes zoster 
 TB Spine 
 Rheumatoid arthiritis 
 SLE 
 Mixed connective tissue disorder. 
COMPLICATIONS: 
 Severe spinal canal stenosis 
 Cauda equina syndrome 
 Neurogenic claudication 
 Paraplegia 
 Conus Medullaris Syndrome 
 
  
                                                                                            
DISCS PROBLEMS 
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                                    MATERIALS AND METHODS 
                    The open  labeled randomized  clinical study on Thandaga Vatham was 
carried out in the post graduate department of pothu maruthuvam, Govt. Siddha 
medical college palayamkottai. For this clinical study 20 patients of both sex at 
different age groups suffering from Thandaga Vatham were selected in the out 
patients and the other 20 as Inpatients.  After discharge Some Inpatients are followed 
by out patient for further management.  
SELECTION OF PATIENTS:                       
INCLUSION CRITERIA: 
   Age: 20-60 yrs. 
   Sex : Both male and female 
    Patients having symptoms of Pain in the low back area, radiating pain to 
buttocks and lower limbs, stiffness present in low back area, Exacerbation of 
pain on movements, Pain increased on forward bending, Tingling sensation. 
    Patients who are willing to give radiological investigation and provide blood 
for lab investigation. 
    Patient willing to sign the informed consent stating that he/she will 
conscientiously stick to the treatment during 30 days but can opt out of the 
trial of his/her own conscious discretion.  
    Patients complaining of back pain functional scale score should be range 
from below 30. 
EXCLUSION CRITERIA: 
 Systemic Hypertension 
 Diabetes mellitus 
 Cardiac disease 
 Auto immune diseases like Rheumatoid arthritis, SLE, Psoriasis, 
Mixed connective tissue disorder. 
 Spina bifida 
 Liver Disease 
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 Pregnancy and lactation 
 Osteo myelitis 
 Renal Disease 
 Tuberculosis in spine 
 Patient with any other serious illness 
 
For this clinical study detailed history is taken from the patient, these are as 
follows 
1. Trauma 
2. Occupation 
3. Family history 
4. Diet  
5. Economical status 
6. Personal history 
DIAGNOSIS: 
 Clinical assessment: 
The diagnosis was made by clinical symptoms are correlated with 
lumbar spondylosis. 
 Siddha assessment: 
               Poriyal aridhal, 
               Pulanal aridhal, 
               Vinathal, 
               Udal thathuklal,  
               Uyir thatukal            
 laboratory investigations: 
                            Blood: 
 TC 
 DC 
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 ESR 
 Hb 
 Blood Urea 
 Serum Creatinine 
 Serum Cholesterol 
 Blood Sugar 
 Fasting 
 Post Prandial 
 Random 
                              Urine: 
 Albumin 
 Sugar 
 Deposits 
 
  
 Radiological assessment 
          Xary lumbar spine  
 AP view 
 Lateral view 
ASSESMENT OF RESULTS 
The results were assessed on the basis of symptomatic relief and back 
pain functional scale. According to this pain scale the questionnaire is filled by 
the patient’s co-operation. 
The Back Pain Function Scale (BPFS) of Stratford et al Over view:  
Stratford et al developed the Back Pain Function Scale (BPFS) to evaluation 
functional ability in patients with back pain. The authors are from McMaster 
University Appalachian Physical Therapy (Georgia) and Virginia Commonwealth 
University.  
Measures:  
(1) Any of your usual work housework or school activities  
(2) Your usual hobbies recreational or sporting activities  
(3) Performing heavy activities around your home  
(4) Bending or stooping  
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(5) Putting your shoes or socks (or stockings or pantyhose)  
(6) Lifting a box of groceries from the floor  
(7) Sleeping  
(8) Standing for 1 hour  
(9) Walking 1 mile  
(10) Going up or down 2 flights of stairs (about 20 steps)  
(11) Sitting for 1 hour  
(12) Driving for 1 hour  
Responses Points 
unable to perform activity 0 
extreme difficulty 1 
quite a bit of difficulty 2 
moderate difficulty 3 
a little bit of difficulty 4 
no difficulty 5 
 
Total score = SUM (points for all 12 measures)  
adjusted total score = (total score) / 60 Interpretation:  
        
• Minimum score: 0  
• Maximum score: 60   
• Maximum adjusted score: 1 (100%)  
• The higher the score the greater the patient's functional ability.  
 
Total Score (Adjusted) Interpretation 
0 (0%)  unable to perform any 
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activity  
60 (100%)  no difficulty in any activity  
References:  
Stratford PW Binkley JM et al. Development and initial validation of the Back Pain 
Functional Scale. Spine. 2000; 25: 2095-2102 (Appendix A page 2101). 
  
  The score is below 30 improvement is poor. 
 The score is 31-50 improvement is moderate. 
 The score is 51-60 improvement is good. 
Treatment: 
 
The clinical trial drug SAGALAVATHA CHOORANAM 
(Internal) 2gm two times after food with water is given for 30 days till the 
end of the course. The Bio - Chemical analysis was done in the Laboratory 
of Government Siddha Medical College of Palayamkottai. Pharmacological 
analysis was done in the laboratory of Periyar College of Pharmaceutical 
sciences, Trichy.   
 
 
 
 
 
 
 
 
 
 
 
Results & Observations
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RESULT AND OBSERVATIONS 
 
For this open labeled randomized phase II Clinical study totally forty patients (20 
OPD+20IPD) were selected. They are treated in Pothu Maruthuvam Department, 
G.S.M.C. Palayamkottai.  
Results were observed with respect to following criteria. 
 Age Distribution 
 Sex Distribution 
 Religion 
 Occupational Status 
  Socio-Economic Status  
 Diet 
  Aetiological Factor  
  Mode of Onset  
  Duration of Illness  
  Clinical Manifestation  
 Kaalam 
 Thegi   
  Gunam  
 Thinai  
 Gnanendrium 
  Kanmendrium  
 Kosam 
  Mukkutram (Vatham, Pitham, Kabham)  
 Udal Kattukal 
  Envagai Thervugal  
 Neerkuri  
 Neikuri 
 Assessment of Outcome 
 Radiological Findings  
 Gradation of results     
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1. Age Distribution: 
Table–1–Illustrates the age distribution and its percentage. 
 
 
 
 
 
 
 
 
Inference: 
              Among 40 cases the prevalence of the disease was found to be higher in the age 
group 51-60. 
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SL.
No. 
Age Group 
in Years 
Out Patients (OP) In Patients (IP) 
No. of 
Cases Percentage 
No. of 
cases Percentage 
1 21-30 4 20 - 0 
2 31-40 6 30 2 10 
3 41-50 6 30 3 15 
4 51-60 4 20 15 75 
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2. Sex Distribution: 
 Table -2-Illustrates the sex distribution and its percentage. 
 
SL. 
No 
Sex 
Out Patients (OP) In Patients (IP) 
No. of 
Cases Percentage 
No. of 
cases Percentage 
1 Male 10 50 11 55 
2 Female 10 50 9 45 
 
 
 
 
    Among 20 out patients:  
                                  50 % of both Males and Females were affected 
    Among 20 In patients: 
                                   55% of Males and 45% of Females were affected. 
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3. Religion Distribution: 
 Table – 3- Illustrates the religion distribution and its percentage. 
SL. 
No. 
Religion 
Out Patients (OP) In Patients (IP) 
No. of 
Cases Percentage 
No. of 
cases Percentage 
1 Hindu 18 90 16 80 
2 Christian 1 5 4 20 
3 Muslim 1 5 - 0 
 
 
Among 20 out patients:  
                                  90 % of cases were Hindus, 5% of cases were both Muslim and          
Christians.  
Among 20 In patients: 
                                   80 % of cases were Hindus, 20% of cases were Christians. 
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4. Occupation: 
 Table -4-Illustrates the Occupation and its percentage. 
 
SL. 
No. 
Occupation 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
No. of 
cases 
Percentage 
1 Agricultural 
labours 
3 15 5 25 
2 Coolie 1 5 2 10 
3 House Wife 9 45 10 50 
4 Tailor 2 10 2 10 
5 Loadman 1 5 - 0 
6 Driver 3 15 - 0 
7 Business 1 5 1 5 
 
 
 
Inference:  
Among 40 cases the prevalence of the disease was found to be higher in house wife’s. 
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5. Socio Economic Status: 
 Table 5- Illustrates the Socio Economic Status and its percentage. 
 
SL. 
No. 
Socio Economic 
Status 
Out Patients (OP) In Patients (IP) 
No. of 
Cases Percentage 
No. of 
cases Percentage 
1 High Income Class - 0 - 0 
2 Middle Income 
Class 
13 65 15 75 
3 Low income Class 7 35 5 25 
 
 
Among 20 out patients: 
              65% of cases were Middle Income class and 35% of cases were Low Income 
class. 
Among 20 In patients: 
              75% of cases were Middle Income class and 25% of cases were Low Income 
class. 
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6. Diet: 
 Table -6-Illustrates the diet distribution and its percentage. 
SL.
No. 
Diet 
Out Patients (OP) In Patients (IP) 
No. of 
Cases Percentage 
No. of 
cases Percentage 
1 Vegetarian 4 20 2 10 
2 Non-Veg 16 80 18 90 
 
 
 
Inference: 
                  Among 40 patients the prevalence of the disease was higher to be found in 
Non vegetarian. 
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7. Aetiological factors: 
 Table-7-Illustrates the aetiological factors and its percentage. 
SL. 
No. 
Aetiological 
factors 
Out Patients (OP) In Patients (IP) 
No. of 
Cases Percentage 
No. of 
cases Percentage 
1 Age 7 35 16 80 
2 Occupation 6 30 4 20 
3 Trauma - 0 - 0 
4 Obesity 7 35 - 0 
 
 
 
Among 20 out patients: 
           Aetiological factors of the disease due to age 35%, occupation and obesity 35% 
were observed. 
Among 20 In patients:     
         Aetiological factors of the disease due to age 80%, occupation 20% were observed 
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8. Mode of Onset: 
         Table – 8 – Illustrates the Mode Onset and its Percentage. 
SL. 
No. 
Mode of 
Onset 
Out Patients (OP) In Patients (IP) 
No. of 
Cases Percentage 
No. of 
cases Percentage 
1 Acute - - - 0 
2 Chronic 20 100 20 100 
 
 
 
 
 
Inference: 
               All the patients were observed in chronic state. 
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9. Duration of Illness:  
   Table – 9 –Illustrates Duration of Illness and its Percentage. 
 
SL. 
No. 
 
DurationofIll
ness 
OutPatients(OP) InPatients(IP) 
No.of 
Cases 
Percentage 
No.of 
cases 
Percentage 
1. 15-30Days 1 5 - 0 
2. 1-3Months 8 40 3 15 
3. 4-6Months 3 15 2 10 
4. 7-12Months 5 25 4 20 
5. >12Months 3 15 11 55 
 
 
Among 20 out patients: 
         Duration of illness 5% in 15 to 30 days 40% in 1-3 months, 25 % in 7-12 months 
and 15 % of both 4-6 months and above 12 months were observed. 
Among 20 In patients:   
      Duration of illness 15% in 1-3 months, 10% in 4-6 months, 20 % in 7-12 months and 
55% in  above 12 months were observed. 
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10. Clinical Manifestation: 
 Table -10- Illustrates Clinical Manifestation and its percentage. 
 
SL. 
No. 
 
Clinical 
Manifestation 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
No. of 
cases 
Percentage 
1 Lumbar Pain  
(low backache) 
20 100 20 100 
2 Rediating pain in 
the lower limbs 
15 75 15 75 
3 Restricted 
movements 
9 45 10 50 
4 Tenderness 4 20 4 20 
5 Numbness 4 20 5 25 
 
 
Inference: 
       Among 40 cases low back pain is found in 100% and Radiating pain is found in 75% 
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11. Kaalam: 
 Table – 11- Illustrates Kaalam and its percentage. 
SL. 
No. 
Kaalam 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
No. of 
cases 
Percentage 
1 Vathakaalam 4 20 - 0 
2 Pithakaalam 16 80 20 100 
3 Kabhakaalam - - - 0 
 
 
 
Inference: 
      Among 40 cases Most of the patients were affected in pitha kalam (80% of OP & 
100% of IP) 
    Remaining 20 % were affected vatha kalam in OP cases. 
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12. Constitution of the Body: 
 Table – 12 – Illustrates Constitution of the body and its percentage. 
 
SL. 
No. 
 
Constistution of 
The Body 
OutPatients(OP) InPatients(IP) 
No.ofCases Percentage No.ofcases Percentage 
1. VathaThegi 9 45 11 55 
2. PithaThegi 3 15 4 20 
3. KabhaThegi 5 25 3 15 
4. ThonthaThegi 3 15 2 10 
 
 
Among 20 Out patients: 
          45% under Vatha thegi   15 % under Pitha thegi, 25% under Kabha thegi, 15% 
under Thontha thegi. 
Among 20 In patients: 
            55% under Vatha thegi, 20 % under Pitha thegi, 15% under Kabha thegi, 10% 
under Thontha thegi  
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13. Gunam: 
 Table-13- Illustrates the Gunam and its percentage. 
 
SL. 
No. 
 
Gunam 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
No. of 
cases 
Percentage 
1 Sathuva 
gunam 
- - - - 
2 Rajo gunam 20 100% 20 100% 
3 Thamasa 
gunam 
- - - - 
 
 
 
Inference: 
Among 40 cases Rajo gunam was affected in 100% of both IP and OP cases were 
observed. 
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14. Thinai: 
 Table 14- Illustrates the Thinai and its percentage. 
 
SL.No. Thinai 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
No. of 
cases 
Percentage 
1 Kurinji - - - - 
2 Mullai - - - - 
3 Marutham 18 90 18 90 
4 Neithal 2 10 2 10 
5 Palai - - - - 
 
 
 
 
INFERENCE: 
       Among 40 patients 90% of both IP and OP cases were reported from Marutham and 
10 % of cases were reported from Neithal 
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15. Gnanendrium: 
 Table 15- Illustrates the Gnanendrium and its percentage. 
SL. 
No. 
 
Gnanendrium 
Out Patients (OP) In Patients (IP) 
No.of 
Cases 
Percentage 
No. of 
cases 
Percentage 
1 Mei 20 100 20 100 
2 Vaai - - - - 
3 Kan - - - - 
4 Mooku - - - - 
5 Sevi - - - - 
 
 
 
 
INFERENCE: 
              Among 40 cases most of the patients were affected Mei (100% of OP&IP) 
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16. Kanmandrium: 
 Table 16- Illustrates the Kanmandrium and its percentage. 
 
SL. 
No. 
 
Kanmandrium 
Out Patients (OP) In Patients (IP) 
No.of 
Cases 
Percentage 
No. of 
cases 
Percentage 
1 Vaai - - - - 
2 Kaal 13 65 15 75 
3 Kai - - - - 
4 Eruvai 7 35 5 25 
5 Karuvai - - - - 
 
 
 
Among 20 out patients: 
          65% of patients were affected in kaal, 35% of cases were affected in Eruvai. 
Among 20 In patients: 
          75% of patients were affected in kaal, 25% of cases were affected in Eruvai 
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17. Kosam: 
 Table1 17- Illustrates the Kosam and its percentage. 
 
SL.
No. 
 
Kosam 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
No. of 
cases 
Percentage 
1 Annamaya 
Kosam 
6 30 6 30 
2 Pranamaya 
kosam 
- - - - 
3 Manomaya 
kosam 
- - - - 
4 Vinganamaya 
kosam 
10 50 11 55 
5 Aanandamaya 
kosam 
- - - - 
 
 
Among 20 out patients: 
            30% of patients were affected in Annamayakosam, 50% were affected in 
Vinganamayakosam. 
Among 20 In patients: 
            30% of patients were affected in Annamayakosam, 55% were affected in 
Vinganamayakosam. 
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18. Condition of Mukkutram: 
 Table 18- Illustrates the Condition of Vaatham and its percentage. 
 
SL.
No. 
 
Condition of 
vaatham 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
No. of 
cases 
Percentage 
1 Piranan - - - - 
2 Abanan 7 35 5 25 
3 Udhanan - - - - 
4 Viyanan 20 100 20 100 
5 Samanan 20 100 20 100 
6 Nagan - - - - 
7 Koorman - - - - 
8 Kirukaran 6 30 6 30 
9 Devathathan 20 100 20 100 
10 Dhananjeyan - - - - 
 
 
Viyanan, Samanan and Devathathan was affected in 100% of the patients in both OP&IP. 
Abanan was affected in 35% of OP& 25% of IP. 
Kirukaran was affected in 30% of both OP&IP patients. 
 
 
0%
20%
40%
60%
80%
100%
0%
35%
0%
100%100%
0% 0%
30%
100%
0%0%
25%
0%
1 0%1 0%
0% 0%
30%
1 0%
0%
P
e
rc
e
n
ta
ge
Condition of Vatham
Condition of Vatham
Out Patients
In Patients
70 
 
18. (a) Disturbance in pitham: 
 Table 18 (a)- Illustrates the Disturbance in Pitham and its percentage. 
SL. 
No. 
Disturbance in 
pitham 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
No. of 
cases 
Percentage 
1 Anala pitham 6 30 6 30 
2 Ranjagam 2 10 2 10 
3 Prasagam - - - - 
4 Alosagam - - - - 
5 Sathagam 20 100 20 100 
 
 
Among the 40 Patients  Anala pitham was affected in 30% of OP & IP cases. 
Ranjagam was affected in 10% of OP cases & 10% of IP cases. 
Sathagam was affected in all 40 cases which produce difficulty in performing regular 
daily activities. 
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18. (b) Disturbance in Kabham: 
 Table 18(b) – Illustrates the Disturbance inKabham and its percentage. 
SL. 
No. 
Disturbance in 
Kabham 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
No. of 
cases 
Percentage 
1 Avalambegam - - - - 
2 Kilaethagam 6 30 6 30 
3 Pothagam - - - - 
4 Tharpagam - - - - 
5 Santhigam 20 100 20 100 
 
 
 
Kilaethagam was affected in 30% of both OP & IP cases. 
Santhigam was affected in 100% of OP & IP cases. 
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19. Involvement of Udalthathukkal: 
 Table 19- Illustrates the Involvement of Udalthathukkal and its percentage. 
SL. 
No. 
UdalThathukkal 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
No. of 
cases 
Percentage 
1 Saaram 20 100 20 100 
2 Senner 20 100 20 100 
3 Oon 20 100 20 100 
4 Kozhuppu 20 100 20 100 
5 Enbu 20 100 20 100 
6 Moolai 20 100 20 100 
7 Sukkilam / 
Suronitham 
20 100 20 100 
 
 
Among 20 Out & In patients: 
 Saaram, Senner, Oon, Kozhuppu, Enbu, Moolai, Sukkilam /Suronitham were 
affected in 100% of Both OP& IP. 
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20. Conditions of EnvagaiThervugal: 
 Table 20- Illustrates the Conditions of Envagai Thervugal and its percentage. 
SL. 
No. 
EnvagaiThervugal 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
No. of 
cases 
Percentage 
1 Naadi 20 100 20 100 
2 Sparisam 4 20 6 30 
3 Naa - - - - 
4 Niram - - - - 
5 Mozhi - - - - 
6 Vizhi - - - - 
7 Maalam 7 35 5 25 
8 Moothiram - - - - 
 
 
Inference: 
 Sparisam was affected in 20% of OP cases & 30% of OP cases. 
Malam was affected in 35% of OP & 25% of IP cases. 
All the OP& IP cases showed Thontha naadi in which Vathapitha naadi was 
predominant.  
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21. Neerkuri: 
 Table 21- Illustrates the Neerkuri condition and its percentage. 
SL. 
No. 
 
Neerkuri 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
No. of 
cases 
Percentage 
1 Niram 6 30 7 35 
2 Manam - - - - 
3 Edai --  - - 
4 Nurai 2 10 4 20 
5 Enjal 2 10 3 15 
 
 
 
Inference: 
 Niram was affected in 30% of OP cases & 35% of IP cases. 
 Nurai was affected in 10% of OP cases & 20% of IP cases. 
 Enjal was affected in 10% of OP cases & 15% of IP cases. 
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22. Neikuri: 
 Table 22- Illustrates the Neikuri Conditions and its percentage. 
SL. 
No. 
Kuttram Neikuri 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
No. of 
cases 
Percentage 
1 Vaatham Spreading like 
snake 
13 65 15 75 
2 Pitham Spreading like ring 3 15 2 10 
3 Kabham Spreading like 
pearl 
2 10 1 5 
4 Thontham AsathiyaNeikurigal 2 10 2 10 
 
 
Among 20 Out patients: 
 65% of patients had Vathaneer, 15% had Pithaneer, 10% had Kabaneer, 10% had 
Thonthaneer. 
Among 20 In patients: 
 75% of patients had Vathaneer, 10% had Pithaneer, 5% had Kabaneer, 10% had 
Thonthaneer. 
0%
10%
20%
30%
40%
50%
60%
70%
80%
Vaatham Pitham Kabham Thontham
65%
15%
10% 10%
75%
10%
5%
10%
P
e
rc
e
n
ta
ge
Neikuri
Neikuri
Out Patients
In Patients
76 
 
 
77 
 
23. Assessment of Outcome: 
 Table 23- Illustrates Back pain functional 
 
SL. 
No 
 
Pain 
Score 
Out Patients (OP) In Patients (IP) 
Before 
Treatment 
After 
Treatment 
Before 
Treatment 
After 
Treatment 
No.Of 
Cases 
 % No. Of 
Cases 
% No. Of 
Cases 
% No. Of 
Cases 
% 
1  1 ≤ 30 20 100 2 10 20 100 2 10 
2  2 31-40 - - 3 15 - - 4 20 
3 41-50 - - 2 10 - - - - 
4 51-60 - - 13 65 - - 14 70 
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(Minimum Score – 0 ,  Maximum Score – 60) 
Pain 
Score 
Improvement 
≤ 30 No 
31-40 Mild 
41-50 Moderate 
51-60 Good 
  
Before treatment high incidence of back pain functional score is reported in the 
range from ≤ 30. 
 After treatment high incidence of back pain functional score is reported in the 
range from 51-60. i.e. 65% of OP and 70% of IP cases had good improvement and 25% 
of OP & 20% of IP cases had moderate improvement. 
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24. Radiological Findings: 
 Table 24- Illustrates Radiological Findings and its percentage. 
SL. 
No. 
Radiological 
Findings 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
No. of 
cases 
Percentage 
1 Degenaration 20 100 20 100 
2 Osteophytic 
Changes 
20 100 20 100 
3 Fusion of IVD - - - - 
4 Altered  lordosis - - - - 
 
 
 
Among 20 OP Patients: 
 100% showed degeneration & osteophyte changes were observed. 
Among 20 IP Patients: 
 100% showed degeneration & osteophyte changes were observed. 
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25. Gradiation of Results: 
 Table 25- Illustrates Gradiation of results and relative percentage.  
SL.
No. 
Results 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
No. of 
cases 
Percentage 
1 
Good 
Response 
13 65 14 70 
2 Fair response 5 25 4 20 
3 Poor response 2 10 2 10 
 
 
 
Among 20 Out Patients: 
 65% of OP cases showed good response, 25% of cases showed fair response. 
Among 20 In Patients: 
 70% of OP cases showed good response, 20% of cases showed fair response
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OUT PATIENTS REPORT 
SL.NO OP.NO NAME AGE/SEX OCCUPATION 
DURATION 
OF 
ILLNESS 
TREATMENT 
STARTING 
DATE 
END OF THE 
TREATMENT 
DATE 
TOTAL 
DAYS 
RESULTS 
1 8417 DURAI 42/M COOLI 1 MONTH 26.1.2016 24.2.2016 30 POOR 
2 8797 MAYILAMMAL 57/F HOUSE WIFE 3 MONTHS 27.1.2016 25.2.2016 30 GOOD 
3 8774 MARIAPPAN 55/M FARMER 2 MONTHS 27.1.2016 25.2.2016 30 GOOD 
4 9631 THANGAM 35/F HOUSE WIFE 2 MONTHS 29.1.2016 27.2.2016 30 GOOD 
5 9949 SELVAKUMAR 49/M DRIVER 3 MONTHS 30.1.2016 28.2.2016 30 GOOD 
6 10029 MAYILMARI 35/F HOUSE WIFE 3 MONTHS 30.1.2016 28.2.2016 30 GOOD 
7 10456 ANTONY 30/M DRIVER 3 YEARS 1.2.2016 1.3.2016 30 FAIR 
8 10464 RANJITHKUMAR 40/M DRIVER 6 MONTHS 1.2.2016 1.3.2016 30 POOR 
9 10971 MURUGASUBRAMANIAN 25/M LOADMAN 8 MONTHS 2.2.2016 2.3.2016 30 GOOD 
10 11301 GANDHI 50/M FARMER 1 YEARS 3.2.2016 3.3.2016 30 FAIR 
11 12377 PARVATHAGANAPATHY 23/F TAILOR 6 MONTHS 6.2.2016 6.3.2016 30 GOOD 
12 13182 LAKSHMI 45/F HOUSE WIFE 2 MONTHS 9.2.2016 9.3.2016 30 GOOD 
13 13761 RANJITHAM 48/F HOUSE WIFE 8 MONTHS 10.2.2016 10.3.2016 30 GOOD 
14 13890 SUBBULAKSHMI 36/F HOUSE WIFE 15 DAYS 11.2.2016 11.3.2016 30 GOOD 
15 14759 SAHUL HAMEED BASHA 36/M BUSINESS 3 MONTHS 13.2.2016 13.3.2016 30 FAIR 
16 14835 SRI RAMAN 21/M TAILOR 7 MONTHS 13.2.2016 13.3.2016 30 FAIR 
17 15377 BAKIYAM 55/F HOUSE WIFE 6 MONTHS 15.2.2016 15.3.2016 30 GOOD 
18 15312 CHANDRASEKAR 48/M FARMER 8 MONTHS 15.2.2016 15.3.2016 30 GOOD 
19 17646 VEMBU 60/F HOUSE WIFE 2 YEARS 22.2.2016 22.3.2016 30 FAIR 
20 20057 ANJALI 33/F HOUSE WIFE 7 MONTHS 29.2.2016 29.3.2016 30 GOOD 
 
 
82 
 
IN PATIENTS REPORT 
SL.NO IP.NO NAME AGE/SEX OCCUPATION 
DURATION OF 
ILLNESS 
DOA DOD 
NO OF 
DAYS 
TOTAL 
DAYS 
RESULTS 
IP OP 
1 209 ESSAKIAMMAL 60/F HOUSE WIFE 1 MONTHS 28.1.2016 29.2.2016 33 - 33 GOOD 
2 219 SHANTHI 50/F HOUSE WIFE 2 YEARS 29.1.2016 29.2.2016 32 - 32 GOOD 
3 221 NALLAMUTHU 60/F HOUSE WIFE 4 MONTHS 29.1.2016 25.2.2016 28 2 30 GOOD 
4 297 MADASWAMY 60/M FARMER 3 YEARS  3.2.2016 23.2.2016 21 9 30 FAIR 
5 326 PARVATHY 60/F HOUSE WIFE 8 MONTHS 8.2.2016 8.3.2016 30 - 30 GOOD 
6 382 MANI 52/M FARMER 2 YEARS 15.2.2016 17.3.2016 32 - 32 GOOD 
7 397 PARVATHY 60/F HOUSE WIFE 1 MONTHS 15.2.2016 7.3.2016 22 8 30 POOR 
8 421 SHUNMUGAKANI 48/F HOUSE WIFE 2 YEARS 17.2.2016 18.3.2016 31 - 31 FAIR 
9 441 CHELLAIYA THEVER 55/M FARMER 10 MONTHS 19.2.2016 21.3.2016 32 - 32 GOOD 
10 589 ANNALAKSHMI 60/F HOUSE WIFE 3 YEARS 4.3.2016 4.4.2016 32 - 32 GOOD 
11 609 SEETHAIAMMAL 60/F HOUSE WIFE 6 MONTHS 7.3.2016 28.3.2016 22 8 30 GOOD 
12 616 MADATHI 35/F HOUSE WIFE 1 YEAR 7.3.2016 27.3.2016 21 9 30 GOOD 
13 707 SEVATHAIYA NADAR 60/M FARMER 1 YEAR 16.3.2016 30.3.2016 15 15 30 POOR 
14 782 RAVI 58/M COOLI 2 MONTHS 24.3.2016 16.4.2016 24 6 30 GOOD 
15 820 PARAMASIVAN 58/M FARMER 3YEARS 27.3.2016 25.4.2016 30 - 30 GOOD 
16 896 MARIYADOSS 60/M BUSINESS 9 MONTHS 2.4.2016 21.4.2016 20 10 30 FAIR 
17 933 LAKSHMI 50/F HOUSE WIFE 1 YEAR 5.4.2016 24.4.2016 20 10 30 FAIR 
18 1017 KUMARAN 40/M TAILOR 3YEARS 16.4.2016 17.5.2016 32 - 32 GOOD 
19 1046 MANI 52/M COOLI 7 MONTHS 19.4.2016 18.5.2016 30 - 30 GOOD 
20 1107 MARIAMMAL 28/F TAILOR 3YEARS 25.4.2016 16.5.2016 22 8 30 GOOD 
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RADIOGRAPHIC FINDINGS AND LABORATORY INVESTIGATIONS (OP PATIENTS) 
SL.NO OP.NO RADIOLOGICAL  FINDING BLOOD 
SUGAR ® 
BLOOD 
UREA 
SERUM 
CHOLESTEROL 
CREATININE 
RA FACTOR 
BT AT BT AT BT AT BT AT 
1 8417 Spondylotic Changes 100 99 20 19 170 172 0.9 0.9 18 
2 8797 Spondylotic Changes 102 100 17 15 160 160 0.7 0.6 18.2 
3 8774 Spondylotic Changes 104 102 15 13 158 162 0.8 0.7 19.1 
4 9631 Spondylotic Changes 90 90 13 13 200 198 0.6 0.6 11 
5 9949 Spondylotic Changes 98 98 22 22 197 195 0.6 0.6 14.2 
6 10029 Spondylotic Changes 100 98 20 18 182 190 0.4 0.5 12.4 
7 10456 Spondylotic Changes 100 100 18 18 180 192 0.6 0.5 12.6 
8 10464 Spondylotic Changes 120 120 19 20 175 180 0.9 0.7 18 
9 10971 Spondylotic Changes 110 109 21 22 168 165 0.7 0.8 19.2 
10 11301 Spondylotic Changes 80 82 23 20 159 150 0.4 0.6 6.7 
11 12377 Spondylotic Changes 82 80 28 26 179 167 0.8 0.7 9.4 
12 13182 Spondylotic Changes 89 86 30 30 183 172 0.6 0.4 8.2 
13 13761 Spondylotic Changes 95 90 32 31 185 185 0.5 0.6 11 
14 13890 Spondylotic Changes 90 92 34 33 192 190 1 0.8 17.4 
15 14759 Spondylotic Changes 90 90 30 30 172 180 0.9 0.7 17.4 
16 14835 Spondylotic Changes 92 92 26 25 169 172 0.7 0.5 12.6 
17 15377 Spondylotic Changes 99 99 29 26 200 200 0.8 0.9 19 
18 15312 Spondylotic Changes 100 98 32 31 210 200 0.4 0.3 18.3 
19 17646 Spondylotic Changes 102 98 28 28 187 191 0.9 0.7 11.6 
20 20057 Spondylotic Changes 104 96 30 26 192 190 1 0.8 12.2 
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RADIOGRAPHIC FINDINGS AND LABORATORY INVESTIGATIONS (IP PATIENTS) 
SL.NO IP.NO RADIOLOGICAL  FINDING 
BLOOD 
SUGAR ® 
BLOOD 
UREA 
SERUM 
CHOLESTEROL CREATININE RA FACTOR 
BT AT BT AT BT AT BT AT 
1 209 Spondylotic Changes 98 97 28 27 190 182 0.5 0.6 17 
2 219 Spondylotic Changes 112 112 32 30 195 180 0.6 0.5 18.2 
3 221 Spondylotic Changes 100 102 25 24 200 200 0.9 0.9 19.4 
4 297 Spondylotic Changes 102 100 26 25 210 200 1 0.9 16 
5 326 Spondylotic Changes 96 95 31 31 185 190 0.8 0.8 13.8 
6 382 Spondylotic Changes 82 82 36 35 192 190 0.8 0.8 16 
7 397 Spondylotic Changes 110 98 28 28 175 180 1 1 17.9 
8 421 Spondylotic Changes 104 96 24 25 181 170 1 0.9 18.4 
9 441 Spondylotic Changes 98 95 21 21 202 200 0.6 0.7 18.4 
10 589 Spondylotic Changes 88 83 37 30 196 195 0.5 0.5 19.2 
11 609 Spondylotic Changes 102 99 28 26 183 173 0.4 0.3 17.9 
12 616 Spondylotic Changes 110 104 25 25 191 190 0.6 0.7 16.4 
13 707 Spondylotic Changes 112 109 29 29 206 200 0.7 0.8 15.8 
14 782 Spondylotic Changes 120 113 19 20 200 195 0.9 0.9 14.4 
15 820 Spondylotic Changes 102 98 18 20 193 192 1.1 1 13.9 
16 896 Spondylotic Changes 96 93 20 21 197 197 0.5 0.4 17.9 
17 933 Spondylotic Changes 87 84 23 20 170 170 0.4 0.6 12.8 
18 1017 Spondylotic Changes 92 88 22 22 173 168 0.4 0.4 13.9 
19 1046 Spondylotic Changes 99 84 20 19 169 172 0.6 0.7 14.7 
20 1107 Spondylotic Changes 103 97 21 18 180 180 0.8 0.7 19.4 
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DISCUSSION 
Thandagavatham is one among the vatha noigal and it is mentioned by 
Yugi Munivar in “Yugi vaithiya Cindhamani-800”. Thandaga vatham clinical 
features can be correlated with lumbar spondylosis in modern medicine. 20 IP 
cases and 20 OP cases were selected for treatment with main clinical features of 
Thandagea vatham is pain in low back area, Stiffness and restricted movements. 
The diagnosis was carried out by modern and siddha diagnostic tools was 
confirmed and treatment with trial medicine were clearly observed. 
The observations were discussed here under: 
1. Incidence with Age Distribution : 
The disease was found to be higher in the age group of 31-50 in OP & 51-
60 in IP (OP-60 % & IP– 75%) 
2. Incidence with Sex Distribution: 
 55% of the In patients were Males and 45% of the In Patients were 
Females 
 55% of the Out patients were Males and 50% of the Out Patients were 
Females 
3. Incidence reference to Religion: 
Among the 40 patients the incidence was found to be higher in Hindus 
(OP- 90% & IP – 80%) 
4. Incidence with reference to Occupation: 
Occupation of most of the patients strained themselves to heavy worker, 
lift heavy weight, long travelling. This may be the reason for these patients to 
develop Thandaga vatham. 
5. Incidence with reference to Socio Economic Status: 
In this clinical study most of patients were from middle income class in 
(OP 65% & IP 7 5 % )  
6.  Incidence with reference to Diet: 
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Most of the patients belongs to non -vegetarian (OP-80% & IP – 90%) 
7. Incidence with reference to Aetiological Factor: 
  Age, obesity occupation were the main precipitating factor in majority of 
the cases. 
8. Incidence with reference to Mode of Onset: 
All the patients were observed in chronic state. 
9. Incidence with duration of illness: 
    Duration of illness in majority of the cases were observed in 1-3 Months in 
OP & above 12 Months in IP. 
10. Incidence with Clinical Manifestation: 
100% of the both OP&IP Patients had Pain in the Low back area. Radiating 
pain is the lower limbs, restricted movements, tenderness, numbness were sign 
and symptoms present in variable number among the patients under the study. 
11. Distribution according to Kaalam: 
Greater part of the cases belonged to Pitha kaalam which is commonly 
the period of degeneration (OP – 80% & IP-100%) 
12. Incidence with reference to Constitution of the Body: 
Vatha thegi patient were more affected (OP-45% & IP-55%) 
13. Incidence with reference to Gunam: 
All inpatients and out patients had Rajogunam. 
14. Incidence with Thinai: 
Most of the cases reported were from Marutham (OP-90% & IP-90%) 
15. Incidence with reference to the Gnanendrium: 
Mei was affected in all cases (100 % in both IP & OP).  
16. Incidence with reference to the Kanmendrium: 
Kaal was affected in 65% of OP cases & 75% of IP cases. Eruvai was 
affected in 35% of OP & 25% of IP Cases. 
17. Incidence with reference to Kosam: 
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Annamaya kosam was affected in 30% of both Op & IP cases.  
Vingana mayakosam was affected in 50% of OP cases & 55% of IP Cases. 
18. Conditions of  Mukkuttram: 
a. Disturbance in Vatham: 
Viyanan and Samanan was affected in 100% of the patients in both OP & IP. 
Abanan was affected in 35% of OP & 25% of IP. 
Kirukaran was affected in 30% of both OP & IP patients. 
b. Disturbance in Pitham: 
Among the 40 patients observed anala pitham was affected in 30% of  
both Op & IP Cases. 
Ranjagam was affected in 10% of OP cases & 10% of IP cases. 
Sathagam was affected in all 40 cases which produce difficulty in 
performing regular daily activities. 
c. Disturbance in Kabham: 
Kilaethagam was affected in 30% of both OP & IP cases .Santhigam 
was affected in 100% of OP & IP cases. 
19. Incidence with reference to Udal Thathukkal: 
Saaram, senner, oon, kozhuppu, enbu,   moolai, sukkilam/suronitham were 
affected in 100% of Both OP & IP. Disturbance of saaram produced symptoms 
like lethargy and mental depression. Disturbance in senner was associated with 
anemia. Disturbance of kozhuppu and enbu produced symptoms like restricted 
movements & osteophytic changes in the lumbar vertebras. 
20. Incidence with reference to Envagai Thervugal: 
Sparism was affected in 20% of Op cases & 30 % of IP cases. 
Maalam was affected in 35% of OP & 25% of IP cases. 
In the study all the Op & IP cases showed thontha naadi in which vathapitha 
naadi was predominant. 
21. Incidence with reference to Neerkuri: 
Niram was affected in 30% of Op cases & 35% of IP cases.            
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Nurai was affected in 10% of OP cases & 20% of IP cases. 
Enjal was affected in 10% of OP cases & 15% of IP cases. 
22. Incidence with reference to Neikuri: 
Neikuri in majority of the cases showed that the oil dropped into the urine 
spreaded like a snake indicating the predominance of Vatha neer. 
23. Incidence with reference to assessment to outcome in both IP & OP: 
After treatment 65% of OP and 70% of IP cases had good improvement,   
25% of OP& 20% of IP cases had moderate improvement.  
24. Incidence with reference to Radiological Studies: 
From  X-ray  lumbar  spine  (AP  &  Laterial  view)  100%  cases  
showed degenerative changes and osteophytic changes. 
25. Incidence with reference to result: 
65% of OP cases and 70% of IP cases showed good response. 25% of OP & 
20% of IP cases showed moderate response.10% of both IP & OP cases showed poor 
response. 
Modern Aspects: 
Routine clinical laboratory investigation (Blood,urine) were done  on 
admission to rule out their abnormalities. X-ray were taken to confirm 
Thandaga vatham. 
Treatment: 
Internally – Sagalavatha Chooranam (2gm twice a day with water). 
Medicines were administered to the patients for 30 days. It was found to 
the End of the results which showed very good clinical improvement. That is 
reducing low back ache and improved vertebra spinal movements. 
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SUMMARY 
 
 
 The disease Thandaga vatham was taken for the clinical study with 
reference in Yugi Vaidhiya Chinthamani. The disease is correlated 
with lumbar spondylosis in modern medicine.  The clinical diagnosis 
was done on the basis of clinical features described in Yugi Vaidhya 
Chinthamani -800. 
 The trial drug was chosen for the clinical study Sagala Vatha 
Chooranam (Internal) 2gms twice a day with water. 
 The Definition, Aetiology, Pathology, Pathophysiology, Clinical 
features, Classification and Prognosis of the diseases were collected 
from a number of literatures both in Siddha System as well as in 
Modern system of medicine. 
 For this study 20 cases were diagnosed clinically and admitted in the 
In patients ward and treated with trial drugs.  Another 20 as Out 
patients.  Most of the patients were followed in the Out patient 
department after discharge. 
 The selection of cases and management of cases during admission and 
after treatment was carried out under the supervision of professor, 
Reader and Lecturer of P.G. Pothu maruthuvam Department. 
 A case sheet proforma was prepared with particular reference to 
focusing Siddha and Modern clinical parameters. 
 This disease predominantly affects males than females. 
 The maximum incidence of age for this disease was between 30-60. 
 To follow the prognosis of the patients the routine blood examination, 
estimation of blood sugar, blood urea, serum cholesterol and 
investigation of urine, were done before and after treatment. 
 The patients taken for the clinical study were observed for a period of     
30 days during and after the course of treatment, no signs of 
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complications were reported. Clinically the trial medicines were used 
only after careful purification process. 
 The pharmacological evaluation of Sagalavatha Chooranam showed 
moderate analgesic action, significant anti- inflammatory action.  No 
acute toxic effects were noted. 
 Bio-chemical analysis of SAGALA VATHA CHOORANAM 
showed the presence of  Calcium, Starch, Ferrous iron, Unsaturated 
compound, Tannic acid and Amino acid. 
 On the basis of symptoms relieved and results observed during the 
study, the clinical improvement was graded as Good, mild, moderate. 
 IN patients were discharged only after satisfactory clinical 
improvement and they are adviced to follow up the OUT patients 
ward. 
 The improvement was observed only clinically and there was no 
changes in radiological findings. 
  At the end of the treatment there was marked reduction of clinical 
symptoms like back pain with stiffness (which is the classical 
symptoms of THANDAGA VATHAM) with sense of well-being. 
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CONCLUSION 
 
 The clinical trial medicine choosen for the clinical study was 
Sagalavatha Chooranam (Internal) 2gms twice a day with water. 
 In this clinical study the trial medicine were free from side effects and 
adverse reactions and also acute toxic effects. 
 The trial medicine has good Pharmacological Action. 
 Sagalavatha Chooranam is moderately reduced the symptoms.  So 
the patients were found to be satisfactory in 70% of cases. 
 In long standing cases fair result were found. 
 So, the Thandaga vatham is controllable disease along with 
Sagalavatha Chooranam. 
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ANNEXURE I 
 
PREPARATION OF TRIAL MEDICINE 
 
PREPARATION OF SAGALA VATHA CHOORANAM 
 
INGREDIENTS: 
 Kodiveli vaer       - 175gms 
 Milagaranai vaer  - 175gms 
 Notchi vaer          - 175gms 
 
METHOD OF PREPARATION: 
           Purified raw drugs are taken and powdered separately.  Then the powders 
of all the drugs are mixed well and then it filtered using pure white cloth and kept in 
airtight container. 
 
DOSAGE         : 2gm Bd 
 
ADJUVANT   : Water 
 
INDICATION: Sagala Vatha  Noigal 
 
EXPIRY          : 3 Months from the Date of Preparation 
 
REFERENCE: Aathmarakshamirtham pg 308 
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PROPERTIES OF THE INGREDIENTS 
 
KODIVELI 
 
BOTANICAL NAME           : Plumbago indica 
FAMILY NAME                   : Plumbaginaceae 
NtW ngah;fs;          : mzpQ;rpy;, mjpfehhp, mjpgJq;fp, moy;, cjhrdd;,  
                  vhp,  vOeh, xyp, fUehfk; , fdyp, fhhpik,   
      nfhbNtyp,  fhdpype;jpud;, fhdpyk;, nfhbr;rp, rpj;jpu%yp,  
      rpj;jpu%yk;, rpj;jpuk;,  nQfpop, joy;, jpf;F, jpireh, 
             tQ;rjhuk;, td;dp, mf;dp, mjprdrp, cjftd;, 
 rjhNtjh, rpj;jpufk;, jgdd;,  jpfdh, trfk;, tdkh,  
 td;dpghpak;, rpj;ufk;, nfhbtd;dp, typtd;dp,  
   jptpgpehkk;. 
PART USED                         :  Root Bark 
SUVAI                                   :  Karppu 
THANMAI                            :  Veppam 
PIRIVU                                  :  Karppu 
 
ACTIONS:  
 Tonic 
 Stomachic 
 Anti -Periodic 
 Diaphoretic 
 Stimulant 
 Rubefacient 
 
 
 
96  
CHEMICAL CONSTITUENTS: 
 Plumbagic Acid 
 Tanin 
 Amino Acids 
 Zeytanone 
 Zylinone 
 Plumbagin 0.91% 
 
nghJFzk;: 
                fl;btpu zq;fpue;jp fhy;fs; miuahg;Gf; 
           fl;;br;# iytPf;fq; fho;%yk;-Kl;buj;jf; 
                fl;LeP Nuw;wq; fdj;j ngUtapWk; 
                ml;Lq; nfhbNtyp ahk; 
 
 fl;b,Gz;, foiy, tspNeha;, miuahg;Gf;fl;b, Fj;jy; ,Nrhig, %yNuhfk,; 
cjpuf;fl;L ePNuw;wk;, ngUtapW, ,itNghk;. 
 
fl;bNa #iyf;fl;L fUjpL Fwpg;Gz; fpue;jp 
xl;LNk fuzj;NjhL KWkiu ahg;G kd;wp 
                tpl;blh newpr;R uk;gpd; tpad;tpl kr;R ue;jhd; 
nghl;nldg; gwe;J NghFk; Gfo;nfhb Ntyp fz;lhy; 
  
 #iyf;fl;L, Fwpg;Gz; , fpue;jp ,Nkfg;Gz; , newpRuk; , er;Rr;Ruk; 
,KjypaitAe; jPUk;. 
 
PURIFICATION PROCESS: 
 
 The root is soaked in lime water for three hairs and then sun dried. 
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MILAKARANAI 
 
BOTANICAL NAME      : Toddalia asiatica 
FAMILY     NAME         : Rutaceae 
PART USED                    : Root Bark 
SUVAI                              : Thuvarpu 
THANMAI                       : Thatpam 
PIRIVU                             : Karpu 
 
ACTIONS: 
 Stimulant 
 Tonic 
 Carminative 
 Diaphoretic 
 Anti-periodic 
CHEMICAL CONSTITUENTS: 
 Resin 
 Essential oil 
 Citric Acid 
 Berberine 
nghJFzk;: 
               Iak fw;Wk; mrPuzth jk;Nghf;FQ; 
               nra;agpj;j #iyfisj; jPh;f;Fq;fhz;-igatUk; 
               <is ,Uky; ,iug;Gg;G re;njhiyf;Fk; 
               ehS kpsfuiz ed;W. 
                                         (m.F) 
 Iak; ,Iag;ngUf;F ,nrhpahj thA ,mfl;LthA ,moy;#iy , Uky,; 
,iug;G, tapw;Wg;gprk;  Mfpa ,itfis ePf;Fk;. 
PURIFICATION PROCESS: 
 The root is clean with water and allowed it to dry. 
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NOTCHI 
 
BOTANICAL NAME   :  Vitex Negundo 
FAMILY NAME           :  Nerbenaceae 
NtW ngah;fs;       : ,e;jpu#hpak;, epj;jpy;, eph;f;Fz;b, neh;f;Fz;b, 
                                             rpe;Jk,rpe;Jthuk; 
PART USED                  :  Root Bark 
SUVAI                            :  Kaipu, Thuvarpu, Karpu 
THANMAI                     :  Veppam 
PIRIVU                           :  Karppu 
ACTIONS:  
 Alterative 
 Vermifuge 
 Febrifuge 
 Expectorant 
 Diuretic 
 Astringent 
 Refrigerant 
CHEMICAL CONSTITUTIONS: 
 Organic Acid 
 Malic Acid 
nghJFzk;: 
              Nehah fypia nehbf;F sUe;jntk;ik 
              Nahah kzhS Kah;j;JjYf;-fha 
              te;jKjy; ez;ghfp thjj;ij Naawthw; 
              rpe;Jth uq;fdYe; jP.           -  (Njud;-ntz;gh)                         
                  fu nehr;rpw; gl;ilaJ Js;Srd;dp thj kfw;Wk; 
                                                  (m.F.) 
 Kg;gpzpAk; tsp NehAk; NghFk;. 
PURIFICATION PROCESS: 
                           The root is cleaned with water and then allowed it to dry. 
INCREDIENTS OF SAGALA VATHA CHOORANAM 
NOCHI VAER                                                             MILAKARANAI VAER 
 
 
 
 
 
 
 
 
         KODIVELI VAER                                 SAGALA VATHA CHOORANAM 
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ANNEXURE - II 
                         BIO CHEMICAL ANALYSIS OF 
                             SAGALA VATHA  CHOORANAM  
PREPARATION OF THE EXTRACT 
5 gms of the drug was weighed accurately and placed in 250ml clean 
beaker. Then 50ml of distilled water is added and dissolved well. Then it is 
boiled well for about 10 minutes. It is cooled and filtered in a 10ml volumetric 
flask and then it is makeup to 100ml with distilled water. This fluid is taken 
for analysis. 
QUALITATIVE ANALYSIS: 
 
SL. 
NO 
EXPERIMENT OBSERVATION INFERENCE 
 
1 TEST FOR CALCIUM: 
          2 ml of the above prepared 
extract is taken in a clean test tube. 
To this add 2ml of 4% Ammonium 
Oxalate solution. 
A white precipitate is 
formed 
Indicates the 
presence of 
calcium 
2 TEST FOR SULPHATE:  
          2ml of the extract is added to 
5% barium chloride solution. 
No white precipitate 
is formed 
Absence of 
Sulphate 
3 TEST FOR CHLORIDE:  
          The extract is added with 
silver nitrate solution 
No white precipitate 
is formed 
Absence of 
Chloride 
4 TEST FOR CARBONATE:  
          The substance is treated with 
concentrated Hcl 
No brisk 
effervessence its 
formed 
Absence of 
Carbonate 
5 TEST FOR STARCH:  
          The extract is added with 
weak iodine solution. 
Blue colour is formed Indicates  the 
presence of starch 
6 TEST FOR IRON FERRIC:  
           The extract is acidified with 
Glacial acetic acid and potassium 
ferrocyanide. 
No Blue colour is 
formed 
Absence of Ferric 
Iron 
7 TEST FOR IRON FERROUS:  
           The extract is treated with 
concentrated Nitric acid and  
Blood red colour is 
formed 
Indicates the 
presence of 
Ferrous Iron 
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Ammonium thiocyanate solution. 
 
8 TEST FOR PHOSPHATE:  
         The extract is treated with 
Ammonium Molybdate and 
concentrated nitric acid. 
No yellow precipitate 
is formed 
Absence of 
Phosphate 
9 TEST FOR ALBUMIN:  
          The extract is trated with 
Esbach’s Reagent. 
No yellow precipitate 
is formed. 
Absence of 
Albumin 
10 TEST FOR TANNIC ACID:  
          The extract is treated with 
ferric chloride. 
Blue black 
precipitateis formed 
Indicates the 
presence of 
Tannic acid 
11 TEST FOR UNSTURATION:   
          Potassium permanganate 
solution is added to the extract. 
It  gets decolourised Indicates the 
presence of 
Unsaturated 
compound 
12 TEST FOR THE REDUCING 
SUGAR:  
          5 ml of Benidict’s qualitative 
solution is taken in a test tube and 
allowed to boil for 2 mts and added 
8-10 drops of the extract and again 
boil it for 2 mts. 
No colour change 
occurs 
Absence of 
Reducing Sugar 
13 TEST FOR AMINO ACID:  
         One or Two drops of the 
extract is placed on a filter paper 
and dried it well. After drying, 1% 
Ninnydrin is sprayed over the same 
and dried it well. 
Violet colour is 
formed 
Indicates the 
presence of 
Amino acid 
14 TEST FOR ZINC: 
          The extract is treated with 
potassium Ferrocyanide. 
No white precipitate 
is formed 
Absence of zinc 
 
INFERENCE: 
Bio chemical analysis of Sagala Vatha chooranam showed the presence 
of Calcium,  Starch, Ferrous Iron, Tannic acid,  Amino acid and   Unsaturated 
compound,  
Annexure - III
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ANNEXURE III 
PHARMACOLOGICAL ANALYSIS OF  
SAGALA VATHA CHOORANAM 
ANALGESIC ACTIVITY 
 
Analgesic activity of Sagalavatha  Chooranam against acetic acid induced writhing 
reflux in mice 
 
Analgesic activity of Sagalavatha  Chooranam at a dose of 100 mg/kg and 200 
mg/kg was evaluated by acetic acid induced writhing reflux in mice. Painful reactions in 
animals may be produced by the chemicals such as phenylquinolone, bradykinin etc. like 
that, acetic acid pain reaction which is characterized as a writhing response. Construction 
of abdomen, turning of trunk (twist) and extension of hind legs are taken as reaction to 
chemically induced pain. Analgesics (both narcotic and non-narcotic) inhibit writhing 
response. 
Requirements 
Animal:                        Swiss albino mice (20 – 25g) either sex 
Drugs and chemicals: Diclofenac sodium (standard), 
               Acetic acid (1%),  
                                     Sagalavatha  Chooranam 
 
Method 
Treatment protocol 
Group- 1: Treated as normal control received 10ml/kg of normal saline through orally 
Group- 2: treated as standard control received 10mg/kg of diclofenac sodium through 
orally 
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Group- 3: treated as Test-I received 100mg/kg of Sagalavatha Chooranam with 2 ml of 
sterile water through orally 
Group- 4: treated as Test- II received 200mg/kg of Sagalavatha  Chooranam with 2 ml of 
sterile water through orally 
Both dose of Sagalavatha Chooranam were administered one hour prior to the 
acetic acid administration. Note the onset on writhing. Record the numbers of abdominal 
contractions, trunk twist and extension of hind limbs as well as the number of animals 
showing such response during a period of 10 minutes were noted. 
Statistics 
Data are expressed as mean ± SEM; data analyzed by one way ANOVA followed 
by Dunnet’s  multiple range tests to determine the significance of the difference between 
the control group and rats treated with extracts. 
* Values were considered significant at P < 0.01. 
Table - 1 
Analgesic activity of Sagalavatha  Chooranam against acetic acid induced 
writhing reflux in mice 
 
 
Treatment Dose (mg/kg) No. of writhing % reduction in 
reaction time 
Group I 
Normal saline 
Inject 1%v/v acetic acid 
1ml/100g of body 
weight 
35.2 ± 2.6 - 
Group II 
Standard 
10mg/kg Diclofenac 
sodium through orally 
7.5 ± 0.7 65.70*** 
Group III 
Sagalavatha  
Chooranam 
100mg/kg administered 
through orally 
 
12.95 ± 0.4 59.01*** 
Group IV 200mg/kg administered 11.92 ± 0.3 61.38*** 
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Sagalavatha  
Chooranam 
through orally 
 
Values are expressed as mean ± SEM  
Values are analysed by one way ANOVA followed by Dunnet’s multiple range tests  
*** Values were considered significant at P < 0.001. 
Results 
The table values show that analgesic activity of Sagalavatha  Chooranam at a 
dose of 100mg/kg and 200mg/kg by acetic acid induced writhing reflex. The result 
reveals that both doses of Sagalavatha  Chooranam possess significant analgesic activity 
at P < 0.001. 
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ACUTE TOXICITY STUDY 
Acute oral toxicity refers to those adverse effects occurring following oral 
administration of a single dose of a  substance or multiple doses given within 24 hours. 
Acute toxic class method (OECD guidelines 423, (2000) was followed to arrive at the 
maximum safety dose of the drug extracts. Three Wistar strain female albino rats (8-12 
weeks old, 180-200g body weight) were used in each group. Single dose (2g/kg) of the 
Sagalavatha  Chooranam was orally administered to overnight fasted (food but not water 
withheld) animas while control animals received the vehicle (0.3%w/v CMC). Animals 
were observed individually after dosing at least once during the first 4 hrs and daily 
thereafter, for a total of 14days. Body weights of the animals were recorded. The other 
observations include changes for skin, fur, eyes and mucous membranes, respiratory, 
circulatory and autonomic and central nervous system and somatomotor activity and 
behavior pattern. At the end of 14 days, all animals were subjected to gross necropsy. 
  Statistics 
Data are expressed as mean ± SEM; data analyzed by one way ANOVA followed 
by Dunnet’s  multiple range tests to determine the significance of the difference between 
the control group and rats treated with test compounds. 
* Values were considered significant at P < 0.5. 
Results 
Acute toxicity study 
All of the rats fed with the food sample showed normal general behavior, respiratory 
pattern, cardiovascular signs, motor activities, reflexes and normal change in skin and fur. 
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Table - 2 
Hematological values of Sagalavatha  Chooranam in the acute toxicity study 
S. No Parameter Control Sample 2g/kg 
1 White blood cells (x103/µl) 9.36±0.54 8.98 ± 0.26 
2 Hemoglobin (g/dl) 11.50±0.26 12.95 ± 0.65 
3 Mean corpuscular volume 60.45±2.3 58.91 ± 0.95 
4 Mean corpuscular hemoglobin 
conc. (g/dl) 
34.56±0.86 28.91 ± 0.39 
5 Platelet (x105/µl ) 5.60±0.52 4.98 ± 0.60 
6 Red blood cell (x106/µl ) 3.87±0.24 2.97 ± 0.35 
 
Values are expresses as Mean ± S.E.M. 
All groups were treated with oral dose of 2g/kg body weight 
No significant different from normal control 
Table - 3 
Blood chemical values of food sample in the acute toxicity study 
S. No Parameter Control Sample 2g/kg 
1  Glucose (mg/dl) 148.75±3.96 132.90 ± 1.92 
2  BUN(mg/dl) 34.26±1.23 29.10 ± 0.51 
3  Creatinine(mg/dl)  0.46±0.06 0.30 ± 0.01 
4  Total protein (g/dl) 5.48±0.23 4.09 ±0.20 
5  Albumin (g/dl) 3.49±0.62 2.91 ± 1.04 
6  Total bilirubin (mg/dl) 0.26±0.02 0.31 ± 0.01 
7  AST (u/l) 141.5±3.76 131.02 ± 1.92 
8  ALT (u/l) 86.36±1.75 90.12 ± 0. 21 
9  ALP (u/l) 75.57±2.16 80.91 ± 0.31 
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Values are expresses as Mean ± S.E.M. 
All groups were treated with oral dose of 2g/kg body weight 
No significant different from normal control 
Discussion and conclusion 
In acute toxicity study for 14 days, at a dose of 2g/kg of Sagalavatha  Chooranam 
sample were chosen for the experiment. In the aspect of general behaviors, the rats 
treated with food sample at a single dose had no signs of behavior changes and toxic 
signs. The treated groups revealed no significant differences in body weight gain. The 
increase in body weight may have resulted from physiological changes in rats such as 
metabolism, food and water intake. However, the result from animal health monitoring in 
the entire period of 14days showed no sign of morbidity and diseases.  
The albino Wistar rats were healthy as shown by the normal appearance of 
general behavior, respiratory pattern, cardiovascular signs, motor activities, reflexes and 
normal change in skin fur. 
With regards to hematological values, most of values in treated groups were 
normal in comparison with the control group. Significantly, some values were different 
from those of the control group such as RBC, MCV, MCHC, and platelet. However, such 
values are within the normal ranges. These variations may have resulted from variation 
among animal groups (Feldman et al., 2000) (Inala et al., 2002). Therefore, these results 
suggest that the test drug did not cause hematological or immunological defects in rats.  
Furthermore, blood chemical examination was performed in order to evaluate any 
toxic effects on liver. In this study, the levels of these blood chemical values were minor 
changes and remained within the normal range (Casley and King, 1980) (Levine, 1995) 
(Angkhasirisap et al., 2002). 
In conclusion, Sagalavatha Chooranam sample given orally to Wistar rats did not 
produce toxicities. 
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ANTI-INFLAMMATORY ACTIVITY 
Anti-inflammatory activity of Sagalavatha  Chooranam against Carrageenan 
induced paw edema in rats 
The anti-inflammatory activities of Sagalavatha  Chooranam at a dose of 
100mg/kg and 200mg/kg body weight were evaluated using Carrageenan induced paw 
edema method. The inflammation was readily produced in the form of edema with the 
help of the irritant such as carrageenan. Carrageenan is a sulphated polysaccharide 
obtained from sea weed (Rhodophyceae) and when injected cause the release of 
prostaglandins by the way it produces inflammation and edema. 
 Requirements 
Animal: Albino rat (180 – 200g)  
Drugs and chemicals: Diclofenac sodium (standard), 
               Carrageenan (1%), Sagalavatha  Chooranam 
    Digital plethysmometer UGO Basile (Italy) 
Method 
The animals were divided into 4 groups each having six animals 
Treatment protocol 
Group- 1: Treated as normal control received 10ml/kg of normal saline through orally 
Group- 2: Treated as standard control received 10mg/kg of diclofenac sodium through 
orally 
Group- 3: Treated as treatment control received 100mg/kg of Sagalavatha  Chooranam 
with 2 ml of sterile water through orally 
Group- 4: Treated as treatment control received 200mg/kg of Sagalavatha  Chooranam 
with 2 ml of sterile water administered through orally 
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A freshly prepared suspension of carrageenan (1% w/v, 0.1ml) was injected to the 
plantar region of left hind paw of each rat. One group was kept as control and the animals 
of the other groups were pretreated with Sagalavatha  Chooranam given through orally 
60 min before the carrageenan treatment. The paw volumes of the test compounds, 
standard and control groups were measured at 60, 120, 180 minutes of carrageenan 
treatment with the help of Digital plethysmometer UGO Basile (Italy). Mean increase in 
paw volume was measured and the percentage of inhibition was calculated. 
 
% anti-inflammatory activity = (Vc – Vt/Vc) x 100 
Where Vt is  mean increase in paw volume in rats treated with test compounds  
Vc is mean increase in paw volume in control group of rats 
Statistics 
Data are expressed as mean ± SEM; data analysed by one way ANOVA followed 
by Dunnet’s multiple range tests to determine the significance of the difference between 
the control group and rats treated with test compounds. 
* Values were considered significant at P < 0.01. 
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Anti-inflammatory activity of Sagalavatha  Chooranam against Carrageenan 
induced paw edema in rats 
Treatment Dose (mg/kg) Paw volume(ml) 
as measured at 3 
hour 
Percentage 
inhibition of paw 
edema 
Group I 
Normal saline 
5ml/kg orally 4.95 ± 0.76  
Group II 
Standard 
10mg/kg Diclofenac 
sodium through  
orally 
1.98 ± 0.26 69.01** 
Group III 
Sagalavatha  
Chooranam 
100mg/kg 
administered 
through orally 
 
3.01 ± 0.45 50.95** 
Group IV 
Sagalavatha  
Chooranam 
200mg/kg 
administered 
through orally 
 
2.08 ± 0.54 51.02** 
Values are expressed as mean ± SEM  
Values are analyzed by one way ANOVA followed by Dunnet’s multiple range tests, to 
determine the significance of the difference between the control group and rats treated 
with the test compounds.  
** Values were considered significant at P < 0.01. 
Results  
Sagalavatha  Chooranam at a dose of 100 and 200mg/kg were tested for their anti-
inflammatory activity by using carrageenan induced rat paw edema method and the 
results are tabulated in table. The results reveals that both doses of Sagalavatha  
Chooranam 100 and 200mg/kg possess significant anti-inflammatory activity when 
compared to control group at p<0.01. 
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ANNEXURE IV 
 PROFORMA OF CASE SHEET 
GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
PRECLINICAL AND PHASE II RANDOMIZED CLINICAL TRIAL ON 
THANDAGA VATHAM (LUMBAR SPONDYLOSIS) WITH 
SAGALAVATHA CHOORANAM 
FORM-I 
(SCREENING AND SELECTION PROFORMA) 
1. Name___________   2. Age_____      3.Gender________ 4.Phone no _________ 
5. OP No/IP No    6. S No. __________  7. Occupation _______ 
 8. Income __________ 
 INCLUSION CRITERIA:  
 Age : 20 - 60Yrs 
 Sex : Both male and female 
 Patients having symptoms of pain in the low back area, radiating pain to 
buttocks and lower limbs 
 Stiffness present in the low back area 
  Exacerbation of pain on movements  
 Pain increased on forward bending ,tingling sensation 
 Patients who are willing for admission and stay in IP for minimum 20-30 
days or willing to attend OPD 
 Patient who are willing to undergo radiological investigation and give 
blood and urine samples for laboratory investigation. 
 Patient willing to sign the informed consent stating than he/she will 
consciously stick to the treatment during 30 days but can opt out of the 
trial of his/her own conscious discretion. 
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 Patients complaining of back pain functional scale score should be range 
from below 30. 
 
EXCLUSION CRITERIA  
 Systemic Hypertension 
 Diabetes mellitus 
 Cardiac disease 
 Auto immune diseases like Rheumatoid arthritis, SLE, Psoriasis, 
Mixed connective tissue disorder. 
 Spina bifida 
 Liver Disease 
 Pregnancy and lactation 
 Osteo myelitis 
 Renal Disease 
 Tuberculosis in spine 
 Patient with any other serious illness     
 
 
                             
Date: 
 
Station: 
 
Signature of the Investigator: 
 
Signature of the Lecturer:                                            Signature of the HOD: 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
PRECLINICAL AND PHASEII RANDOMIZED CLINICAL TRIAL ON 
THANDAGA VATHAM (LUMBAR SPONDYLOSIS) WITH 
SAGALA VATHA CHOORANAM 
FORM l A 
 
HISTORY PROFORMA ON ENROLLMENT 
 
1. Serial No of the case:   _________          2. OP/IP No:_______ 
 
3. Name: ______________4. Gender:     Male                  Female    
 
5. Age (years): _________             DOB:            
                                  
6. Address: _________________________ 
                     _________________________ 
                     _________________________ 
7. A. Occupation: ________________ B. Nature of work ________________ 
 
8. Educational Status:   A) Illiterate           B) Literate          
 
 
9. Height: ________ cms          10.Weight: ________kg 
 
11. Complaints and Duration:   
____________________________________________________________________ 
 
_____________________________________________________________________ 
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12. Past History:                    
Systemic Hypertension   ______________    
Diabetes mellitus       ______________      
Asthma       ______________     
 PT         ______________ 
 
13. Habits: 
    
A) Smoking: 1. Yes             Duration _____ years; Number - _____     2. No  
 
B) Alcoholism: 1. Yes            Duration _____ years;   Quantity-____ ml 2. No  
 
C) Tobacco chewing: 1. Yes               Duration ____ years     2.No 
                                     
D) Betel chewing:  1. Yes                Duration ______years     2.No 
 
14. Dietary style: A. Pure vegetarian                B. Non-vegetarian                 
 
15. Drug history: Had the patient been treated before with allopathy drug?  
 
                                A) Yes                                2) No                                     
 
16. Marital status:   1.Married         2.Unmarried                                                  
 
17. Family history: 
 
  Whether this problem runs in family?   1. Yes                     2.No   
  
  If yes, mention the relationship of affected person(s) 
__________________________________________________                                                                                                                   
 
18. Bowel habits & micturition:      Normal  
  
114 
 
 History of habitual constipation    1.Yes                     2.No                                                       
 
            History of frequent diarrhoea        1.Yes                      2.No                                                         
 
            History of frequent dysuria            1.Yes                      2.No                
 
19. Psychological state: Normal             Anxiety             Depression           
 
 
 
 Date:   
   
  Station: 
 
 
  Signature of the Investigator: 
 
 
 
  Signature of the Lecturer:                                                  Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
PRECLINICAL AND PHASE II RANDOMIZED CLINICAL TRIAL ON 
THANDAGA VATHAM (LUMBAR SPONDYLOSIS) WITH 
SAGALA VATHA CHOORANAM 
FORM II & II-A 
 
CLINICAL ASSESSMENT ON ENROLLMENT AND ON VISITS 
 
1. S.NO:  _______                                             2. OP/IP NO : __________                            
      3.  Name: _______________________              4. Gender      : __________    
      5. Date of Assessment: _____________  
SIDDHA SYSTEM OF EXAMINATION: 
1. ENVAGAI THERVU: [EIGHT-FOLD EXAMINATION] 
 I. NAADI: [PULSE PERCEPTION] 
  
0stDay 
 
07thDay 
 
15th Day 
 
21st Day 
 
28th Day 
 
30th Day 
Vali       
Azhal       
Iyyam       
Vali Azhal       
Azhal vali       
Iyya vali       
Vali Iyyam       
Azhal Iyyam       
 Iyya Azhal       
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II. . SPARISAM: [PALPATORY PERCEPTION] 
0th Day  7th day 14th Day 21st Day 28thDay 30th day 
Warmth/ 
Cold/ 
 Sweat 
Warmth/ 
Cold/ 
Sweat 
Warmth/ 
 Cold/ 
Sweat 
Warmth/ 
Cold/ 
Sweat 
Warmth/ 
Cold/ 
Sweat 
Warmth/ 
Cold/ 
Sweat 
 
III NAA:[TONGUE] 
 
 
  0th Day 07th Day  14th Day   21st Day 28th Day 30th Day 
Colour Dark/         
Yellow/ 
Red/       
Pale 
Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ 
Pale 
Taste Sweet/ 
Bitter/ 
Sour/ 
Pungent/ 
None 
Sweet/ 
Bitter/ 
Sour/ 
Pungent/ 
None 
Sweet/ 
Bitter/ 
Sour/ 
Pungent/ 
None 
Sweet/ 
Bitter/ 
Sour/ 
Pungent/ 
None 
Sweet/ 
Bitter/ 
Sour/ 
Pungent/ 
None 
Sweet/ 
Bitter/ 
Sour/ 
Pungent/ 
None 
Coating Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Fissure Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Saliva Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Dryness Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Glossitis Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
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IV.NIRAM: COMPLEXION 
 
 
 
 
 
  
V.VIZHI: [EYES] (Lower palpebral conjunctiva) 
 
 
VI.MOZHI: [VOICE] 
 
VII. MALAM; [BOWEL HABITS / STOOLS] 
0th Day 07th 
day 
14th 
Day 
21st 
Day 
28th 
Day 
30th 
day 
Dark/ 
Yellow/
Tinted/ 
Pale 
Dark/ 
Yellow/
Tinted/ 
Pale 
Dark/ 
Yellow/
Tinted/ 
Pale 
Dark/ 
Yellow/
Tinted/ 
Pale 
Dark/ 
Yellow/
Tinted/ 
Pale 
Dark/ 
Yellow/
Tinted/ 
Pale 
0th Day  07th day 14th Day 21st Day 28th Day 30th day 
Dark/ 
Yellow / 
Red/ Pale 
Dark/ 
Yellow/ 
Red/ Pale 
Dark/ 
Yellow/ 
Red/ Pale 
Dark/ 
Yellow/ 
Red/ Pale 
Dark/ 
Yellow/ Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ Pale 
0th Day  07th day 14th Day 21st Day 28th Day 30th day 
Medium/ 
High/ 
Low / 
Pitched 
Medium/ 
High/ 
Low/ 
Pitched 
Medium/ 
High/ 
Low/ 
pitched 
Medium/ 
High/ 
Low/ 
pitched 
Medium/ 
High/ 
Low/ pitched 
Medium/ 
High/ 
Low/ pitched 
 0th Day 07th Day 14th Day  21stDay 28th Day 30th day 
Colour Dark/ 
Yellow/ 
Red/ Pale 
Dark/ 
Yellow/ 
Red/ Pale 
Dark/ 
Yellow/ 
Red/ Pale 
 Dark/ 
Yellow/ 
Red/ Pale 
Dark/ 
Yellow/ 
Red/ Pale 
Dark/ 
Yellow/ 
Red/ Pale 
Consistency Solid/ 
Semisolid/ 
Watery 
Solid/ 
Semisolid/ 
Watery 
Solid/ 
Semisolid/ 
Watery 
Solid/ 
Semisolid/ 
Watery 
Solid/ 
Semisolid/ 
Watery 
Solid/ 
Semisolid/ 
Watery 
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VIII. URINE EXAMINATION: 
 
 
 
 
 
Stool  bulk                          Normal/ 
Reduced 
 
Normal/ 
Reduced 
Normal/ 
Reduced 
Normal/ 
Reduced 
Normal/ 
Reduced 
Normal/ 
Reduced 
Constipation   Present/ 
Absent 
 
Present/ 
Absent 
 
Present/ 
Absent 
 
Present/ 
Absent 
 
Present/ 
Absent 
 
Present/ 
Absent 
 
Diarrhoea Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
NEERKURI 0th Day  07th day 14th Day 21st Day 28th Day  30th Day 
Niram 
[Colour]   
White/ 
Yellowish/ 
Straw 
coloured/ 
Crystal 
clear 
White/ 
Yellowish/
Straw 
Coloured/ 
Crystal 
clear 
White/ 
Yellowish/ 
Straw  
coloured/ 
Crystal 
clear 
White/ 
Yellowish/ 
Straw  
coloured/ 
Crystal 
clear 
White/ 
Yellowish/ 
Straw  
coloured/ 
Crystal 
clear 
White/ 
Yellowish/ 
Straw  
coloured/ 
Crystal 
clear 
Manam 
[Odour] 
Present/  
Absent 
 Present/  
Absent 
Present/  
Absent 
Present/  
Absent 
Present/  
Absent 
Present/  
Absent 
Nurai 
[Froth] 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Edai 
[Sp.gravity]                                
Normal/ 
Increased/ 
Reduced
  
Normal/ 
Increased/
Reduced 
Normal/ 
Increased/
Reduced 
Normal/ 
Increased/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
Enjal 
[Deposits] 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Volume   Normal/ 
Increased/ 
Reduced 
Normal/ 
Increased/
Reduced 
Normal/ 
Increased / 
Reduced 
Normal/ 
Increased/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
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2. THEGI: [TYPE OF BODY CONSTITUTION]    
Vatham predominant  Kabam predominant  
Pitham predominant  Thondha udal  
 
3. NILAM: [LAND WHERE PATIENT LIVED MOST] 
  Kurinji            Mullai             Marutham              Neithal               Palai 
     (Hilly terrain)    (Forest range)         (Plains)          (Coastal belt)      (Arid regions)  
 
4. KAALAM: 
Kaarkalam             -                  Pinpanikalam   -    
Koothirkalam  -                      Ilavenil             - 
Munpanikalam  -                      Muthuvenil - 
 
5. GUNAM: 
Sathuvam   -                    Rasatham  -                    Thamasam  - 
 
NEIKURI 
0th 
Day 
7th 
day 
14th 
Day 
21st 
Day 
28th 
Day 
30th 
Day 
Serpentine 
fashion 
      
Annular/Ringed 
fashion 
      
Pearlbeaded 
fashion    
      
Mixed fashion       
Other fashion       
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6.IMPORIGAL (SENSORY ORGANS): 
 
  
 
7. KANMENDRIYAM :( MOTOR ORGANS) 
 
 
 
 
 
 
 
 
 
 
 
 
IMPORIGAL 0th Day 7th day 14th Day 21st Day 28th Day 30th Day 
Mei  
(Skin) 
      
Vai 
(Buccal 
Cavity) 
      
Kann 
(Eye) 
      
Sevi 
(Ear) 
      
Mooku 
(Nose) 
      
KANMENDRIYAM 0th 
Day 
 7th 
day 
14th 
Day 
21st 
Day 
28th 
Day 
30th 
Day 
Kai  
(upper limb) 
      
Kaal  
(lower limbs ) 
      
Vai    
(buccal cavity) 
      
Eruvaai 
(excretory organs) 
      
Karuvaai  
(reproductive organs) 
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8. KOSANGAL :( Sheath)   
 
KOSANGAL 0th Day  7th day 14th Day  21st Day 28th Day 30th Day 
Annamaya  
Kosam 
      
Pranamaya kosam        
Manomaya 
kosam  
      
Vignanamaya 
kosam  
      
Ananthamaya 
kosam  
      
 
9. MUKKUTRAM: [AFFECTION OF THREE HUMORS] 
 
A) VATHAM: 
 
VATHAM 0th Day  7th day 14th Day 21st Day 28th Day 30th Day 
Praanan       
Abaanan        
Viyaanan       
Udhaanan       
Samanan       
Naagan       
Koorman       
Kirukaran       
Devathathan       
  
122 
 
Dhananjeyan       
 
B) PITHAM:   
 
PITHAM 0th Day  7th day 14th Day 21st Day 28th Day 30th Day 
Analapitham        
 Ranjagam       
Saathagam       
Praasagam       
Aalosagam       
 
C) KABHAM: 
 
KABHAM 
0th 
Day 
7th 
Day 
14th 
Day 
21st 
Day 
28th 
Day 
30th 
Day 
Avalambagam       
Kilaethagam       
Pothagam       
Tharpagam       
Santhigam       
 
10. SEVEN DHATHUS: (7 SOMATIC COMPONENTS)  
SEVEN DHATHUS 
0th 
Day 
7th 
day 
14th 
Day 
21st 
Day 
28th 
Day 
30th 
Day 
Saaram [Chyme]       
Senneer [Blood]        
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11. SYSTEMIC EXAMINATION: 
 
SYSTEMIC 
EXAMINATION 
0th 
Day 
 7th 
Day 
14th 
Day 
21st 
Day 
  28th 
Day 
30th 
Day 
Locomotor system       
 
Cardiovascular 
system 
 
 
     
 
Respiratory system     
 
 
     
Gastro intestinal 
system 
     
 
 
     
Central nervous 
system  
 
 
     
Urogenital system       
Endocrine system       
 
 
Oon [Muscle]       
Kozhuppu [Fat]       
Enbu [Bones]       
Moolai 
[Bonemarrow] 
      
Sukkilam/Suronitham 
[Genital discharges] 
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12. GENERAL EXAMINATION: 
GENERAL 
EXAMINATION 
0th Day 7th Day  14th Day  21st Day 28th Day 30th Day 
Height (cms)       
Weight (kg)       
Temperature (F0)          
Pulse rate (per min)       
Heart rate (per min)       
Respiratory rate 
(per min) 
      
Blood pressure 
(mm/Hg) 
      
Pallor       
Jaundice       
Cyanosis       
Lymphadenopathy       
Pedal edema       
Clubbing       
Jugular vein 
pulsation 
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13. CLINICAL SYMPTOMS: 
 
 
 
COMPLAINTS 
0th Day 7th Day 15th Day 30th Day 
Pain in low back area     
Nature of pain     
Onset of pain     
Radiating pain to buttocks     
Radiating pain in right 
lower limb 
    
Radiating pain in left lower 
limb 
    
Pain increased on forward 
bending 
    
  Sensory loss on  
   affected area 
    
Numbness     
Tenderness     
Restriction of movements     
Burning sensation in its 
lower extremites 
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The Back pain function scale (BPFS) of Stratford et al 
over view 
Stratford et al developed the Back Pain Function Scale (BPFS) to evaluation 
functional ability in patients with back pain. The authors are from McMaster 
University Appalachian Physical Therapy (Georgia) and Virginia Commonwealth 
University.  
Measures:  
(1) Any of your usual work housework or school activities  
(2) Your usual hobbies recreational or sporting activities  
(3) Performing heavy activities around your home  
(4) Bending or stooping  
(5) Putting your shoes or socks (or stockings or pantyhose)  
(6) Lifting a box of groceries from the floor  
(7) Sleeping  
(8) Standing for 1 hour  
(9) Walking 1 mile  
(10) Going up or down 2 flights of stairs (about 20 steps)  
(11) Sitting for 1 hour 
(12) Driving for 1 hour  
 
Responses Points 
unable to perform activity 0 
extreme difficulty 1 
quite a bit of difficulty 2 
moderate difficulty 3 
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a little bit of difficulty 4 
no difficulty 5 
 
Total score = SUM (points for 12 measures) 
Adjusted total score = (total score) / 60 Interpretation:  
• Minimum score: 0  
• Maximum score: 60   
• Maximum adjusted score: 1 (100%)  
• The higher the score the greater the patient's functional ability.  
 
Total Score (Adjusted) Interpretation 
0 (0%)  unable to perform any 
activity  
60 (100%)  no difficulty in any 
activity  
 
References:  
Stratford PW Binkley JM et al. Development and initial validation of the Back Pain 
Functional Scale.  
Spine. 2000; 25: 2095-2102 (Appendix A page 2101). 
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14. BACK PAIN FUNCTIONAL SCALE SCORE: 
 
 
SL. 
NO 
PATIENT’S 
ACTIVITIES 
NORMAL 
SCORE 
PATIENT’S 
SCORE 
1 Any of your usual work house 
work or school activities 
5  
2 Your usual hobbies recreational 
or sporting activities 
5  
3 Performing heavy activities 
around your house 
5  
4 Bending or stooping 5  
5 Putting your shoes or socks 5  
6 Lifting a box of groceries from 
the floor 
5  
7 Sleeping 5  
8 Standing for 1 hour 5  
9 Walking 1 mile 5  
10 Going up or down2 flights of 
stairs (20 steps) 
5  
11 Sitting for 1 hour 5  
12 Driving for 1 hour 5  
   
 (Minimum Score 0, Maximum Score 60) 
 
PAIN SCORE BEFORE TREATMENT AFTER TREATMENT 
   
 
Date:       
Station: 
Signature of the Investigator: 
 
Signature of the Lecturer:                                        Signature of the HOD 
  
129 
 
       
15. CLINICAL   EXAMINATION:  
 A. INSPECTION: 
 0th 
Day 
7th 
Day 
14th 
Day 
21st 
Day 
28th 
Day 
30th 
Day 
Attitude       
Muscle 
Wasting 
      
Swelling       
 
B.PALPATION: 
 0th 
Day 
7th 
Day 
14th 
Day 
21st 
Day 
28th 
Day 
30th 
Day 
Tenderness       
Muscle spasm       
Local heat       
Local lymph 
adenopathy 
      
Pitting oedema       
Joint stiffness       
 
C.MOVEMENTS: 
 0th 
Day 
7th 
Day 
14th 
Day 
21st 
Day 
28th 
Day 
30th 
Day 
Stiffness       
Restriction of 
movements 
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Rotation       
Flexion       
Extension       
Lateral 
bending 
      
 
 
Date:  
Station: 
 
 
Signature of the Investigator: 
 
 
 
Signature of the Lecturer :     Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
POST-GRADUATE DEPARTMENT OF POTHU MARUTHUVAM 
PRECLINICAL AND PHASE II RANDOMIZED CLINICAL TRIAL ON 
THANDAGA VATHAM (LUMBAR SPONDYLOSIS) WITH 
SAGALA VATHA CHOORANAM 
FORM III-LABORATORY INVESTIGATIONS 
1 Sl. No  2 OP/IP No  
3 Bed No  4 Name  
5 Age  6 Gender  
 
I.BLOOD 
        Before Treatment      After Treatment 
1 
 
TC (cells/mm)   
2 
 
DC (%)   
 a)Neutrophils  
 
 
 b)Lymphocytes  
 
 
 c)Monocytes  
 
 
 d)Eosinophils  
 
 
3 
 
ESR(mm)   
 a)1/2 hour  
 
 
 b)1 hour  
 
 
4 
 
Haemoglobin   
5 
 
Blood sugar   
6 
 
Blood urea   
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7 
 
Serum creatinine   
8 
 
Serum cholesterol   
9 RA Factor   
 
II.URINE 
 
  
 
      Before Treatment      After Treatment 
1 
 
Albumin 
 
  
2 Sugar 
 
  
3 Epithelial cells 
 
  
4 Pus cells 
 
  
5 Red blood cells 
 
  
6 Casts/Crystals 
 
  
 
 
III.RADIOLOGICAL FINDINGS 
 
 
X-RAY 
FINDINGS 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
   
 
 
Date: 
       
Station: 
 
 
Signature of the Investigator: 
 
 
Signature of the Lecturer:                                           Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF MARUTHUVAM 
PRECLINICAL AND PHASE II RANDOMIZED CLINICAL TRIAL ON 
THANDAGA VATHAM (LUMBAR SPONDYLOSIS) WITH 
SAGALA VATHA CHOORANAM 
CONSENT FORM-IV A 
Certificate by Investigator 
 I certify that I have disclosed all details about the study in the terms readily understood 
by the patient. 
Date: ……………..      Signature: …………………………. 
  Name: …………………………….. 
                                                               Consent by Patient 
              I have been informed to my satisfaction, by the attending physician, the purpose of the 
clinical trial, and the nature of drug treatment and follow-up including the laboratory investigations 
to be performed to monitor and safeguard my body functions. 
    I am aware of my right to opt out of the trial at any time during the course of the trial 
without having to give the reasons for doing so. 
      I, exercising my free power of choice, hereby give my consent to be included        
             As a subject in the clinical trial of   SAGALA VATHA CHOORANAM for the 
management of THANDAGA VATHAM (LUMBAR SPONDYLOSIS)  
Date: ………………..          Signature: ………………………………… 
                                                                    Name: ……………………………………. 
Date: ……………….           Signature of Witness: ……………………. 
                                                                    Name………….. …………………………   
                                                                    Relationship: ……………………………. 
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murpdH  rpj;j kUj;Jtf;  fy;Y}hp kw;Wk; kUj;Jtkid 
ghisaq;Nfhl;il 
gl; l Nkw;gbg;G nghJ kUj;Jtj;Jiw 
rfythj #uzj;jpd; gupfupg;Gj;jpwidf; fz;lwpAk; kUj;Jt Ma;T Xg;Gjy; 
gbtk; Ma;thsuhy; rhd;wspf;fg;gl;lJ. 
ehd; ,e;j Ma;itf; Fwpj;j midj;J tpguq;fisAk; Nehahspf;F GupAk; 
tifapy; vLj;Jiuj;Njd; vdW cWjpaspf;fpNwd;. 
Njjp:                ifnahg;gk;: 
,lk;:          ngau;: 
Nehahspapd; xg;Gjy; 
vd;dplk; ,e;j kUj;Jt Ma;tpd; fhuzj;ijAk; kUe;jpd; jd;ik kw;Wk; 
kUj;Jt topKiwiag; gw;wpAk; njhlu;e;J vdJ cly; ,af;fj;ij 
fz;fhzpf;fTk>; mjidg; ghJfhf;fTk; gad;gLk; kUj;Jt Ma;Tf;$l 
gupNrhjidfs; gw;wpAk; jpUg;jp mspf;Fk; tifapy; Ma;T kUj;Jtuhy; 
tpsf;fpf; $wg;gl;lJ. 
 
ehd; ,e;j kUj;Jt Ma;tpd; NghJ fhuzk; vJTk; $whky; vg;nghOJ 
Ntz;LkhdhYk; ,e;j Ma;tpypUe;J vd;id tpLtpj;Jf; nfhs;Sk; cupikia 
njupe;jpUf;fpd;Nwd;. 
 
ehd; vd;Dila Rje;jpukhfj; Nju;Tnra;Ak; cupikiaf; nfhz;L jz;lf 
thjk; Neha;f;fhd¸ rfythj #uzj;jpd; gupfupg;Gj; jpwidf; fz;lwpAk; 
kUj;Jt Ma;tpw;F vd;id cl;gLj;j xg;Gjy; mspf;fpNwd;. 
 
Njjp: ifnahg;gk;: 
,lk;: ngau;: 
rhl;rpf;fhuh; ifnahg;gk;: 
ngau;:  
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
PRECLINICAL AND PHASE II RANDOMIZED CLINICAL TRIAL ON 
THANDAGA VATHAM (LUMBAR SPONDYLOSIS) WITH 
SAGALA VATHA CHOORANAM 
FORM IV B 
WITHDRAWAL FORM 
Name: ________________________       OPD/ IPD number: __________ 
Age   : ________      
Date of trial commencement: ___________ 
Date of withdrawal from trial: ___________ 
Reasons for withdrawal: 
 Long absence at reporting     : Yes                 No 
 Irregular treatment      : Yes                 No 
 Shift of locality                                                 : Yes                 No 
 Increase in severity of symptoms               :Yes                  No 
 Development of severe adverse drug reactions: Yes                 No 
Date:      
Station:   
SIGNATURE OF INVESTIGATOR:                                       
SIGNATURE OF LECTURER:      SIGNATURE OF HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF MARUTHUVAM 
 
PRECLINICAL AND PHASE-II RANDOMIZED OPEN CLINICAL STUDY ON 
THANDAGA VATHAM (LUMBAR SPONDYLOSIS) WITH 
SAGALA VATHA CHOORANAM 
 
FORM IV C 
PATIENT INFORMATION SHEET 
 
 It is a degenerative disc disease. 
 This disease is not contagious. 
 It primarily affects joint sand typically results in radiating pain to lower limbs and 
stiffness present lumbar region. 
 Many herbal and mineral siddha medicines are currently practiced by the siddha 
practioners for this disease. 
 The trial drug is prescribed only with evidence of siddha literature. 
 The trial drug is prepared at the Gunapadam lab of government siddha medical 
college & hospital,palayamkottai, under the   direct supervision of teaching 
faculties of   Maruthuvam and Gunapadam Dept. 
 
 
Details of the trial drug: 
    Drug               :  Sagalavatha Chooranam 
    Dose    :   2gms; twice a day. 
    Adjuvant   :  water   
    Duration  :  30 days.   
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
PRECLINICAL AND PHASE II RANDOMIZED CLINICAL TRIAL ON 
THANDAGA VATHAM (LUMBAR SPONDYLOSIS) WITH 
SAGALA VATHA CHOORANAM 
FORM   IV E 
ADVERSE DRUG REACTION FORM 
 
Name: ________________________       OPD/ IPD No  : __________ 
Age: ________      
Date of trial commencement: ___________ 
Date of withdrawal from trial: ___________ 
Description of adverse reaction: 
_______________________________________________ 
_________________________________________________________________ 
 
Date: 
Station:       
SIGNATURE OF INVESTIGATOR:                                  SIGNATURE OF   HOD 
          
                      
 
SIGNATURE OF LECTURER: 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
PRECLINICAL AND PHASE II RANDOMIZED CLINICAL TRIAL ON 
THANDAGA VATHAM (LUMBAR SPONDYLOSIS) WITH 
SAGALA VATHA CHOORANAM 
FORM IV –E 
(DRUG COMPLIANCE FORM) 
Name  :   __________________   Age /sex:__________       S.No:_________ 
OP/IP No: ____________               Date:____________      Bed No:________     
Name of the Drug  :  SAGALA VATHA CHOORANAM 
Drugs issued date :  
Drugs returned date : 
 
S.NO DATE 
DRUG TAKEN TIME 
MORNING TIME EVENING TIME 
Day 1    
Day 2    
Day 3    
Day 4    
Day 5    
Day 6    
Day 7    
Day 8    
Day 9    
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Date: 
Station:     
SIGNATURE OF INVESTIGATOR:   
 
SIGNATURE OF LECTURER:                                         SIGNATURE OF HOD 
 
Day 10    
Day 11    
Day 12    
Day 13    
Day 14    
Day 15    
Day 16    
Day 17    
Day 18    
Day 19    
Day 20    
Day 21    
Day 22    
Day 23    
Day 24    
Day 25    
Day 26    
Day 27    
Day 28    
Day 29    
Day 30    
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